Ë 1 æ.» (æ æå Èß Ë 1) ISBN :

Size: px
Start display at page:

Download "Ë 1 æ.» (æ æå Èß Ë 1) ISBN :"

Transcription

1 π«ß π È ªìπ ËÕß Õ àß ÿ æ Õß â π ÿ æ Ë À æ ß ËÕπ ß À«ßº π â ß â ªí À ÿ æ Õß π Õ à ß ª æ ÿâ à âõ π π µà ßÊ π π«ß π È à à âõ ß Õß ªØ µ ºŸâ â ªØ µ µ µà ß ª âõ π π â π Ë π å µ µà ßÕÕ ªÀ Õ Àµÿº Ë «â«ë ªìπ Ë Õ π ß Ë 1 æ.» (æ æå Èß Ë 1) ISBN :

2 π À Õ Õ Õß ªìπ Ëæ àõ Àπ Ëß Õß ß ª ªìπ Àµÿ µ Ë πõ π µâπê Õߪ» π ÈÀ à â π à«ß «æ µ Õ ªí ÿ π «À à Ë âº â à Ë Õ ßÀ Õ Õ â«à «à ÿà ß µà âõ â π «à «Õ µâõß«π Ë Àâ Ë Õ π 3 Ë«ßÀ ß Õ ßπ Èπ πæ µà ßÊ ßµâÕß µ «æ âõ π â π ÿ Õ π Ë æ ËÕ Àâ Õß «π È âõ à ß ª æ Ëß π π Ȫ» ß à π«ß π À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ Ë ªìπ µ π «π πª «π π Ë ªìπ π æ ß â π ß ª âµ Àπ ߪí À ß à «ß â Õ «à«õ π ß«µà ßÊ π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ æ ËÕ ªìπ π«ß π Ÿ À Õ Õ Õßµ Õÿ µ πœ Àâ ª æ À«ß Àâ ª πå à æ å ÿ ºŸâ Ë «âõßõ à ß â ß π Ë π «Ÿâ Ë â ªªØ µ â Ÿ µâõß ªìπ µ π «π Ë«ª» π π ßπ È 1. ª ÿ ß πºÿâ ß ÿ «ÿ ºŸâ Ë «Èß Ë 1 π«π Ë 3 π ª ÿ ß πºÿâ ß ÿ «ÿ ºŸâ Ë «Èß Ë 2 π«π Ë 20 π ª ÿ ß πºÿâ ß ÿ «ÿ ºŸâ Ë «Èß Ë 3 π«π Ë 2 æƒ ª ÿ ß πºÿâ ß ÿ «ÿ ºŸâ Ë «æ ËÕæ π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ œ Àâ «Ÿ å π«π Ë 16 ÿπ π 2549 æ ËÕ æ æå Èß Ë 1 º æ àµàõ ª Õ à ß Áµ π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ œ π È ªìπ π π π Ëß Ë «à ªØ µ à π Èπ Èßπ È π ªØ µ ß Èπ ÿ æ π Õß æ åºÿâ Ÿ ºŸâªÉ«π Èπ ªìπ π â π È πª «À«ß ªìπÕ à ß Ëß«à π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ œ π È ª πå À æ å Ë π ªª ÿ µå â æ ËÕ À⪠π ÿ æ «µ Ë π Õ π È à Õ Õ ÿ ºŸâ Ë «æ» µ å À «µà ß Ê ª «Ààߪ» À Õ Õ Õß Ààߪ» Ë â Àâ «à«õ ªìπÕ à ß π «Èß æ å «ß ÿ Ë π πÿπ π πß π Èßπ ÈÕ à ß Ëß (π π) ºŸâÕ π«πª «

3 π ºŸâ π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ 1. π.æ. ÿ «å µ ÿ«π π å ˪ 2. π.æ. π ª π 3. π.æ. µ«ÿµ Õߪ π 1 4. π.æ. ÿ µ À æ Ÿ å ÿ Õߪ π 2 5. æ..»π å µ πµ ƒ» Ï Õߪ π 3 6.».π.æ.π æπ å æ«ß«π å ß π 7. æ.µ.æ.. µ πõ ÿ«µ å ß π 8. æ.õ.º».π.æ. π π π πå ß π 9.».æ.. µπ ß π 10.».æ..π» ß å ß π 11. π.æ. ß å π ππ å ß π 12. π.æ. π µ ÈßÕ ÿ» ªá ß π 13. π.æ.æ å æ ß π 14. æ..æ æ» ÿ æ ß π 15. π.æ.õ «ÿ ««ÿ ß π 16. π.æ. ÿ» Ï π å ß π 17. π.æ. µµ µ Õ π ÿ ß π 18. π.æ. Õ «π ÿ ß π 19. æ.. «µπå À«ßº æ π» ß π 20. π ß ÿ ÿ Õß» ß π 21. π ß ß» ÿ «ß π 22. æ.. π Õ Îπ«ß»å πÿ 23. π..õ µ ºŸâ à«πÿ ºŸâª πß π : π.æ. µ«ÿµ æ..»π å µ πµ ƒ» Ï

4 π À Õ Õ Õß ªìπ Ëæ àõ Àπ Ëß Õß ß ª ªìπ Àµÿ µ Ë πõ π µâπê Õߪ» π ÈÀ â à π à«ß «æ µ Õ ªí ÿ π «À à Ë âº àπ Ë Õ ßÀ Õ Õ â«à «à ÿà ß µà âõ â π «à «Õ µâõß«π Ë Àâ Ë Õ π 3 Ë«ßÀ ß Õ ßπ Èπ πæ µà ßÊ ßµâÕß µ «æ âõ π â π ÿ Õ π Ë æ ËÕ Àâ Õß «π È âõ à ß ª æ Ëß π π Ȫ» ß à π«ß π À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ Ë ªìπ µ π «π πª «π π Ë ªìπ π æ ß Õß ß ª âµ Àπ ߪí À ß à «ß â Õ «à«õ π ß«µà ßÊ π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ œ æ ËÕ ªìπ π«ß π Ÿ À Õ Õ Õßµ Õÿ µ πœ Àâ ª æ àõ Àâ ª πå πæ µà ßÊ πõ π Ë æ π Àâ Èπ ªìπº Àâ Ÿ ºŸâªÉ«À Õ Õ Õßµ Õÿ µ π 𪻠µ π Ÿß Èπ ߪ πåµàõª π Ë Á ªÉ«Õ à ß â ß ÀâÕ µ µ π È ß ºŸâªÉ«Ë Õ «µ ÿ æ «µ Ë ªìπª Ë ÿ æ ª Õ Õ æ â ß â ª πå Àâ à Õ «ß ª» µ À ºŸâ Ë π π«ß π Ÿ À Õ Õ Õßµ Õÿ µ π â«ë Õ œ ª â µâõß µ Àπ «à π«ßπ È ª Õπ π π À ªØ µ à π Èπ Èßπ È Èπ ÿ æ π Õß æ å ºŸâ Ÿ ºŸâªÉ«π π Õ π π À à π È ªª ÿ µå â Àâ À µà æ Èπ ˵àÕ ª 29 ÿπ π 2549 ºŸâ

5 Àπâ π» æ Õß ßæ Ë π π À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ 2 π«ß ºŸâªÉ«À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ 3 âõ àß È âõàâ π ºŸâªÉ«À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ 5 À Ë Õ ßÀ Õ Õ 6 «âõπ 8 Monitor and care during and after thrombolytic treatment 9 Elevated Blood Pressure Treatment Sheet for Thrombolytic Therapy 10 Õ Õâ ßÕ ß 11 ºπ«1. NIHSS score sheet The Barthel Index, The Modified Rankin Scale µ «Õ à ß Stroke fast track care maps and protocols æ» µ å ÿã ß å À « æ» µ å ßæ À «À æ» µ å» æ À «À πª «æ å «ß ÿ CT scan examples for early signs of cerebral ischemia Stroke Unit 46

6 µ ß Àπâ µ ß Ë 1 Doctorûs orders 9 µ ß Ë 2 Elevated blood pressure treatment for thrombolytic therapy 10 µ ß Ë 3 The Modified National Institutes of Health Stroke Scale 16 µ ß Ë 4 The Barthel Index 18 µ ß Ë 5 The Modified Rankin Scale 19

7 π À Õ Õ Õß (stroke, cerebrovascular disease) ªìπ Ëæ àõ πºÿâ ŸßÕ ÿ Ë«πª» Ëæ π â«æ «à ªìπ Àµÿ µ Ë ªìπÕ π 3 Õß À «Áß À 𪻠π ˪ÿÉ π æ «à ªìπ Àµÿ µ Õ π 2 Õß À «(1) πª» â» Õ µ «ÿ Õß À Õ Õ Õß π ÿ π Õß π«π 1,361 π ÿß æ À π ËÕªï æ.» æ «à Õ µ (2) à 690/100,000 Õߪ ËÕ ÿ π 20 ªï à ÿ πªï æ.» â» «πª ºŸâ ŸßÕ ÿ ( π 60 ªï) π π 4 Ë«ª» 3,036 æ «à Õ µ «ÿ Õß À Õ Õ Õß â ß ª 𪻵à ßÊ Ë«(1) ßπ Èπ À Õ Õ Õß ß ªìπ Ë «Ëß Àπ Ëß Õߪ «π«ß π È Õß å Õπ â Àπ «Õß À Õ Õ Õß «â ßπ È çrapidly developed clinical signs of focal (global) disturbance of cerebral function lasting more than 24 hours or leading to death, with no apparent cause other than a vascular originé (3) «π À Õ Õ Õß ß ß Õ«à «π ß π ªìπ Ëß ºŸâªÉ«À Õ Õ Õßπ Èπ à«π À à Õ ß ª ªìπ æ Ë àπ ÕàÕπ ß Ëß π æÿ π µ Õß à ÀÁπ Õß ÀÁπ æ âõπ «π» ËÕ À à π È ªìπÕ à ß æ π Õ à ß Áµ ºŸâªÉ«ß Õ Õ àõ ªìπ àõ ª π 2-3 «π À Õ Èπ â««ß â(4) â ºŸâªÉ«ªí Ë ß à«π πÿπ «π À Õ Õ Õß Ëß Èπ àπ «π À µ Ÿß À«π Ÿ ÿà Ë À «ªìπµâπ ªí ÿ π«ºÿâªé«à Õ Õ Õß âæ π Õ à ßµàÕ π ËÕß «Ë â Õ πªí ÿ π «Àπ Ëß â à Àâ Ë Õ ßÀ Õ Õ π À Õ Õ Õßµ Õÿ µ π Ëß âõ π π π À ª àπ «π Ë Àâ Ë Õ π 3 Ë«ßÀ ß Õ ªØ µ π πæ Ë «æ âõ ß â π ÿ ÀâÕßªØ µ ÀπૺŸâªÉ«π ªìπµâπ π ß Ààß πª» ß àæ âõ Ë ªî Àâ Ë Õ πºÿâªé«à Õ Õ Õßµ Õÿ µ π π 3 Ë«ß Õ Ÿà 2 â π Õ â πºÿâ Àâ à «æ âõ Õß πæ Ë Àâ Èß π â π π Ë ÿ Ë Ë «âõß â πºÿâ ß «à â Õߪ π Ë ß â«à º «ß à «â ßµâπ ªìπª πå µà ÁµâÕß ª æ π å À⪠π â «à À Õ Õ Õß Õ Õ à ß µâõß æ æ å Á«Ë ÿ à Ë Á«â ß âº «ÈßµâÕߪ æ π å«à Àπà«ß π Àâ «π È â â«âõ ß à «ß Àâ πæ π«π â ÿ «æµà ßÊ â«π ËÕß Õ ß æ åõ à ßæÕ æ ß µà à π π â ßπ Èπ π«ß À Õ Õ Õßµ À ÕÕÿ µ π â«ë Õ ßÀ Õ Õ π È ß Èπ æ ËÕ àß» æ ÕßÀπà«ß π Àâ Àâ Ë Õ ß à «â Õ π Àâ Õ µ µ Õ µ æ µ Õ π «µ «π ßæ à â à π æ «

8 » æ Õß ßæ Ë π π À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ π µâõß Àâ 24 Ë«ß πà «âõ ßµàÕ ªπ È 1. ª æ å À Õ æ å µ å ÿ π/õ ÿ æ å Ë â ª»π µ Ωñ Õ Àâ Ë Õ (rt-pa) πºÿâªé«à Õ Õ Õßµ Õÿ µ π π æ π â Õß π Ë â Õ π µ 2. ª» æ å 3. CT brain 4. ÀâÕßªØ µ Ë µ «blood sugar, CBC, coagulogram, electrolyte, BUN, Cr 5. À Õ à«πª Õ Õß Õ â àπ fresh frozen plasma, cryoprecipitate, platelet concentrate pack red cell 6. ICU À Õ Stroke Unit (SU) ( Ÿ ºπ«5) 7. Õß rt-pa «â «Ë Àâ àπ ER, ICU À Õ SU 8 π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ

9 ºπ Ÿ Ë 1 π«ß ºŸâªÉ«À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ ºŸâªÉ«Ë Õ ß À Õ Õ Õß π 3 Ë«ß æ ª «µ 1. π ÕàÕπ ß â ß â ßÀπ Ëß π 2. æÿ à æÿ à â À Õøíß à â π 3. π «π» π 4. µ ÀÁπ æ âõπà Õ «â ß â ßÀπ Ëß π 1. µ µàõ æ å* 2. «æ basic life support 3. µ µàõ CT brain 4. µ µàõ ICU À Õ SU Õ µ «blood sugar, CBC, coagulogram, electrolyte, BUN, Cr. º CT brain àæ Õ ÕÕ π Õß æ Õ ÕÕ π Õß ª µ æ å* 1. µ «Õ âõ àß È- âõàâ Àâ Ÿ ËÀπâ 5 2. Õ «π Õ Àâ Ÿ ËÀπâ 31, µ µàõª» æ å àõπ Àâ 4. Àâ â Ë ER/ICU/SU Ÿ ºπ Ÿ Ë 2 * ª æ å À Õ æ å µ å ÿ π/õ ÿ æ å Ë â ª»π µ Ωñ Õ œ π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ 9

10 ºπ Ÿ Ë 2 π«ß ºŸâªÉ«À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ Ë ER/ICU/SU ER/ICU/SU ΩÑ «ßÕ à ß â µ stroke fast track care map and protocal ºπ«3 CT brain È 24. À ß Àâ À Õ ËÕ Õ «ß à «âõπ - ß µ «âõπ À ß Àâ Àâ µàõµ CPG for ischemic stroke/ Stroke fast track care map* Àâ «âõπ ( Ÿ ËÀπâ 8) * µ µàõ Õ â Ëß π π πÿπ«πª «10 π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ

11 âõ àß È âõàâ π ºŸâªÉ«À Õ Õ Õßµ Õÿ µ π (5, 6, 7, 8) â«ë Õ ßÀ Õ Õ âõ àß È 1. ºŸâªÉ«â «π «à ªìπ À Õ Õ Õßµ Õÿ µ π π 3 Ë«ß 2. Õ ÿ «à 18 ªï 3. Õ ß ª Ë «â â NIHSS 4. º CT scan Õß Õß ÈÕßµâπ àæ «Õ ÕÕ 5. ºŸâªÉ«À Õ µ â ª πå Ë Èπ π Õ Àâ â Ë Õ âõàâ 1. Õ Õß À Õ Õ Õßµ Õÿ µ π Ë à «Ë Ë ªìπÕ à ß π À Õ Õ À ß µ ËππÕπ 2. Õ Õß Õ ÕÕ µâ Èπ ËÕÀÿâ Õß (subarachnoid hemorrhage) 3. Õ ß ª ÈπÕ à ß «Á«À Õ Õ Õ à ß «à ÿπ ß (NIHSS < 4) 4. Õ ß ª Õ à ß ÿπ ß (NIHSS > 18) 5. Õ ËÕ Ë Õ À Õ Õ Õßµ Õÿ µ π Èßπ È 6. «π À µ π à«ß àõπ Àâ Ÿß (SBP > 185 mmhg, DBP > 110 mmhg) 7. ª «µ Õ ÕÕ π Õß àõπ 8. ª «µ ªìπ À Õ Õ Õß À Õ Á Ë» ÿπ ß π 3 Õπ 9. â µâ π Áßµ «Õß Õ (heparin À Õ warfarin) π 48 Ë«ß À Õ à partial-thromboplastin time º ª µ À Õ à prothrombin time «à 15 «π À Õ à International normalized ratio (INR) «à ª Á Õ πâõ «à 100,000/mm ª «µ ºà µ À à π 14 «π 12. Õ ÕÕ π ß πõ À À Õ ß πªí «π 21 «π 13. πè µ π Õ µë «à 50 mg/dl (2.7 mmol/l) À Õ Ÿß «à 400 mg/dl (22.2 mmol/l) π«â Glucose (blood) 1 mg/dl = mmol/l ª «µ myocardial infarction π 3 Õπ 15. À Õ Õ ß πµ Àπàß Ë à Àâ Õ â π 7 «π 16. æ Õ ÕÕ À Õ Á ( Ÿ À ) µ «à ß 17. º CT brain æ π ÈÕ Õßµ «à 1 (hypodensity > 1/3 cerebral hemisphere) À Õæ ª Ë π ª ß π ÕßÀ Õ Õ Õßµ π À à àπ æ Õß «mass effect, sulcal effacement π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ 11

12 À Ë Õ ßÀ Õ Õ ª «À recombinant tissue-plasminogen activator (rt-pa) Ë Õ Ÿà 𪻠πªí ÿ π ËÕ Actilyse (R) Ëß 2 π Õ 50. À Õ 100. µàõ 1 àõß π 1 àõß ª Õ â«ºß rt-pa 1 «πè Ë𪻠ÈÕ 50 1 «Á º «ºß «πè Ëπ 1 Õ π Á À Ÿ 2 Õ π Á æ» Àâ ßÀ Õ Õ 1 Õ π syringe 10 1 Õ π ÿ Àâ ßÀ Õ Õ 1 ÿ ( Ÿ Ÿª Ë 1 2) ÈπµÕπ À ßπ È - 𫪠µ πè Àπ µ «ºŸâªÉ«ª 0.9./. ( π Õß Ÿß ÿ à π 90.) - Õ â «rt-pa Ë À µ Ë π«â - º «πè Ëπ «ºß â Á Ë Õ Ÿà π ÿ ÀâπÈ Ëπ À ªº Õ Ÿà π «ºß - â syringe Ÿ ˺ ⫪ 10% Õß π Ë π«â â«â À Õ Õ π 1 π -µàõ «Ë À Õ â ÿ Àâ ßÀ Õ Õ Ë À â À Õ Õ π 60 π ËÕµâÕß Àâ Õ Ëπ ßÀ Õ Õ Àâ Ë Õ «Àâ ßÀ Õ Õ âπõ Ëπ âõ ««ß 1. À Ë ß Àâ µâ π Á Õ À Õ µâ π Áßµ «Õß Õ π 24 Ë«ß Õß 2. µâõßà ÿ Àâ rt-pa π Ë ß «à «Õ ÕÕ π Õß µ ««π æ âõ Èߪ ª» æ å π 3. à «àà Õ ÀâÕ À «Èß ßÀ Õ Õ À à (central venous access) À Õ ßÀ Õ Õ ß π 24 Ë«ßÀ ß Àâ rt-pa 4. À Ë ß à «πªí «π à«ß «Ë Àâ À Õ À ß Àâ 30 π 5. «ÿ «π À µ à Àâ Ÿß Àâ SBP < 185 mmhg, DBP < 110 mmhg π ËÕß «π À µ Ÿß Ë ßµàÕ Õ ÕÕ π Õß â 12 π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ

13 Ÿª Ë 1 recombinant tissue-plasminogen activator (rt-pa) Ÿª Ë 2 «ÿõÿª å Àâ recombinant tissue-plasminogen activator (rt-pa) π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ 13

14 «âõπ «Ë Õ ÕÕ π Õß πºÿâªé«ë â Ë Õ 1. Õ Õ ß Ë ß «à Õ ÕÕ π Õß - Õ ß ª Ë «ßÕ à ß æ π - ª - «π À µ Ÿß ÈπÕ à ß æ π - Ëπ âõ π 2. «ªØ µ ßπ È - À ÿ Àâ rt-pa - àߺÿâªé«ct brain π - Õ µ «PT, aptt platelet count - µ FFP ª 10 cc/kg - âß æ åª «À Õ æ åºÿâ Ÿ 3. ËÕ Õ ÕÕ π Õß - µ «Õ º µ «PT, aptt platelet count - ª ª» æ å π - Àâ FFP 10 cc/kg - ª ÿ ª π«ß à«π ß â π» Õ ÿ - æ CT scan È æ ËÕ Ÿ«à ª Ë π ª ß Õß π Õß âõπ Õ À Õ à π 24 Ë«ß 14 π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ

15 MONITOR AND CARE DURING AND AFTER THROMBOLYTIC TREATMENT µ ß Ë 1 Doctorûs orders ORDER FOR ONE DAY ORDER FOR CONTINUATION - rt-pa mg IV bolus in 1 minute then - NPO except medications for 24 hrs - rt-pa mg IV drip in 60 minutes - Bed rest - Check vital signs, neurological sign & NIHSS - IV fluid as appropriate after infusion - Record I/O q 15 mins. for 2 hrs. - Medication consider then q 30 mins. for 6 hrs. 1. H 2 receptor blocker/proton pump inhibitor then q 60 mins. until 24 hrs. 2. Antihypertensive drugs if BP > 185/110 - If SBP > 185 or < 110 mm Hg, mmhg ( ŸÀπâ 10) DBP > 110 or < 60 mm Hg please notify doctor - Within 24 hrs after rt-pa infusion, Avoid insertion Foley catheter, NG tube, central venous access, arterial puncture & intramuscular injection If intracranial hemorrhage is suspected 1. Stop infusion of the thrombolytic drug. 2. Repeat CBC, platelet, INR, PTT, PT 3. Emergency CT brain 4. Consult neurosurgeon 5. Cross matching for FFP 6 to 8 units (or 10 cc/kg) π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ 15

16 Elevated Blood Pressure Treatment Sheet for Thrombolytic Therapy Desired BP : SBP not more than 180 mmhg and DBP not more than 105 mmhg Check BP q 15 min. for 2 hrs, then q 30 min. for 6 hrs and finally q hr for 16 hrs µ ß Ë 2 Elevated blood pressure treatment for thrombolytic therapy BP level Treatment If DBP > 140 mmhg Sodium nitroprusside 0.5 ug/kg/min. IV infusion as initial dose and titrate to desired BP If SBP > 180 or DBP > 105 but < 140 mmhg Nicardipine 5 mg/h IV infusion as initial dose and titrate to desired effect by increasing 2.5 mg/h q 5 min to maximum of 15 mg/h; If BP is not controlled, consider sodium nitroprusside 16 π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ

17 Õ Õâ ßÕ ß 1. π æπ å æ«ß«π å. Epidemiology of stroke. π : π æπ å æ«ß«π å,. À Õ Õ Õß (Stroke) ß Èß Ë 2 ÿß æ À π : Õπ â«æ æå, 2544: Viriyavejakul A, Poungvarin N, Vannasaeng S. The prevalence of stroke in urban community of Thailand. J Neurology 1985; 232 (suppl): World Health Organization Meeting on Community Control of Stroke and Hypertension. Control of stroke in the community: methodological considerations and protocol of WHO stroke register. CVD/s/73.6 Geneva: WHO, Adams H P Jr, Brott TG, Crowell RM, et al. Guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1994; 25: The National Institute of Neurological Disorders and Stroke rt-pa Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: Adams HP, Brott TG, Furlan AJ, et al. Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke: a statement of healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Circulation. 1996; 94: Adams HP, Adams RJ, Brott T, et al. Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003; 34: The National Institute of Neurological Disorders and Stroke rt-pa Stroke Study Group. Tissue Plasminogen Activator for Acute Ischemic Stroke CT, computed tomography; NIHSS, National Institute of Health Stroke Scale; NINDS, National Institute of Neurological Disorders and stroke. N Engl J Med 1995; 333(24): Henry JB. Clinical diagnosis and management by laboratory methods. 18 th ed., WB Saunders Co Masur H, Papke K, Althoff S, et al. Scales and Scores in Neurology: Quantification of Neurological Deficits in Research and Practice, Druckhaus Gotz. Ludwigsburg. 2004; Herndo RM. Handbook of Neurologic Rating Scales, Demos Vermande: 386 Park Avenue South. New York. 1997; , 178, Hacke W, Lees K, Toni D, et al. Acute stroke treatment. Update 2006 (An educational slide kit), product by infill Kommunikation through an educational grant from Boehringer Ingelheim GmbH. (Actilyse). 2006; Royal College of physician of London, National clinical guidelines for stroke. Second edition, The Lavenham Press Ltd. London. 2004; π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ 17

18 ºπ«1 NIHSS score sheet The National Institutes of Health (NIH) Stroke Scale 10 Application: Stroke Area: Scientific studies Duration: minutes Range of results: 0-36; the more points, the more sever the stroke sequelae References: Brott T, Adams HP, Olinger CP et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989; 20: Level of consciousness 0 Alert, keenly responsive 1 Drowsy, but arousable by minor stimulation to obey, answer, or respond 2 Stuporous, requires repeated stimulation to attend, or lethargic or obtunded, requiring strong or painful stimulation to make movements 3 Coma, responds only with reflex motor or autonomic effects, or unresponsive Level of consciousness-questions Ask patient the month and his/her age. Score first answer. 0 Answers both correctly 1 Answers one correctly 2 Incorrect Level of consciousness-commands Ask patient to open/close hand and eyes. Score if he or she makes unequivocal attempt. 0 Obeys both correctly 1 Obeys one correctly 2 Incorrect Pupillary response 0 Both reactive 1 One reactive 2 Neither reactive 18 π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ

19 Best gaze 0 Normal 1 Partial gaze palsy; abnormal but not forced deviation 2 Forced deviation (total gaze paresis) Confrontation testing using finger movements, inculding double simultaneous stimulation. Use visual theat if consciousness or comprehension limit testing, scoring ç1é for any asymmetry demonstrated. Best visual 0 No visual loss 1 Partial hemianopia 2 Complete hemianopia, to within 5 degrees of fixation Facial palsy 0 Normal 1 Minor 2 Partial 3 Complete Best motor-arm Arms held for 10 sec at 90 degrees if sitting, 45 degree if lying. Grade weaker arm. Place arms in position if comprehension reduced. 0 No drift in 10 sec 1 Drift, after brief hold 2 Cannot resist gravity, falling immediately but some effort made 3 No effort against gravity Best motor-leg While lying, patient to hold weaker leg raised 30 degrees for 5 sec. Place leg if comprehension reduced. 0 No drift in 5 sec 1 Drift, lowering within 5 sec 2 Cannot resist gravity, falling to bed but some effort made 3 No effort against gravity π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ 19

20 Plantar reflex 0 Normal 1 Equivocal 2 One extensor 3 Bilateral extensor Limb ataxia Finger-nose and heel-to-shin tests performed; ataxia is scored only if out of proportion to weakness. If total paralysis, score as absent. 0 Absent 1 Present in arm or leg 2 Present in arm and leg Sensory Tested with pin; only hemisensory loss scored. If comprehension or consciousness reduced, only score if obvious evidence. 0 Normal 1 Partial loss, subjectively different but still felt 2 Dense loss, unaware of being touched Neglect 0 No neglect 1 Partial neglect, visual, tactile, or auditory 2 Complete neglect, affecting more than one modality Dysarthria 0 Normal articulation 1 Mild to moderate dysarthria, slurring some words 2 Near unintelligible or worse 20 π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ

21 Best language Assessed from response during evaluation. 0 No aphasia 1 Mild to moderate aphasia; naming errors, paraphasia, etc. 2 Severe aphasia 3 Mute π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ 21

22 The Modified National Institutes of Health Stroke Scale 11 µ ß Ë 3 The Modified National Institutes of Health Stroke Scale Item Name Response 1A Level of consciousness 0 = Alert 1 = Not alert, but arousable easily 2 = Not alert, obtunded 3=Unresponsive 1B Questions 0 = Answers both correctly 1 = Answers one correctly 2 = Answers neither correctly 1C Commands 0 = Performs both tasks correctly 1 = Performs one task correctly 2 = Performs neither task correctly 2 Gaze 0 = Normal 1 = Partial gaze palsy 2 = Total gaze palsy 3 Visual fields 0 = No visual loss 1 = Partial hemianopsia 2 = Complete hemianopsia 3 = Bilateral hemianopsia 4 Facial palsy 0 = Normal 1 = Minor paralysis 2 = Partial paralysis 3 = Complete paralysis 5 Motor arm 0 = No drift a. Left 1 = Drift before 10 seconds b. Right 2 = Falls before 10 seconds 3 = No effort against gravity 4 = No movement 6 Motor leg 0 = No drift a. Left 1 = Drift before 5 seconds b. Right 2 = Falls before 5 seconds 3 = No effort against gravity 4 = No movement 22 π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ

23 µ ß Ë 3 The Modified National Institutes of Health Stroke Scale (µàõ) Item Name Response 7 Ataxia 0 = Absent 1 = One limb 2 = Two limbs 8 Sensory 0 = Normal 1 = Mild loss 2 = Severe loss 9 Language 0 = Normal 1 = Mild aphasia 2 = Severe aphasia 3 = Mute or global aphasia 10 Dysarthria 0 = Normal 1 = Mild 2 = Severe 11 Extinction/inattention 0 = Normal 1 = Mild 2 = Severe There are 15 items in this version of the NIHSS. Complete scale with instructions can be obtained from the National Institute of Neurological Disorders and Stroke (Lyden et al., 1994). π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ 23

24 ºπ«2 The Barthel Index µ ß Ë 4 The Barthel Index 1. Feeding 10 = Independent. Able to apply any necessary device. Feeds in reasonable time. 5 = Needs help, i.e., for cutting. 0 = Inferior performance. 2. Bathing 5 = Performs without assistance. 0 = Inferior performance. 3. Personal Toilet 5 = Washes face, combs hair, brushes teeth, shaves (manages plug if electric razor) (grooming) 0 = Inferior performance. 4. Dressing 10 = Independent. Ties shoes, fastens fasteners, applies braces. 5 = Needs help but does at least half of task within reasonable time. 0 = Inferior performance. 5. Bowel Control 10 = No accidents. Able to use enema or suppository if needed. 5 = Occasional accidents or needs help with enema or suppository. 0 = Inferior performance. 6. Bladder Control 10 = No accidents. Able to care for collecting device if used. 5 = Occasional accidents or needs help with device. 0 = Inferior performance. 7. Toilet Transfers 10 = Independent with toilet or bedpan. Handles clothes, wipes, flushes, or cleans pan. 5 = Needs help for balance, handling clothes or toilet paper. 0 = Inferior performance. 8. Chair/Bed 15 = Independent, including locks of wheelchair and lifting footrests. Transfers 10 = Minimum assistance or supervision. 5 = Able to sit, but needs maximum assistance to transfer. 0 = Inferior performance. 9. Ambulation 15 = Independent for 50 yards. May use assistive devices, except for rolling walker. 10 = With help for 50 yards. 5 = Independent with wheelchair for 50 yards, only if unable to walk. 0 = Inferior performance. 10. Stair Climbing 10 = Independent. May use assistive devices. 5 = Needs help or supervision. 0 = Inferior performance. 24 π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ

25 µ ß Ë 5 The Modified Rankin Scale Grade Description 0 No symptoms at all. 1 No significant disability despite symptoms: able to carry out all usual duties and activities. 2 Slight disability: unable to carry out all previous activities but able to look after own affairs without assistance. 3 Moderate disability: requiring some help, but able to walk without assistance. 4 Moderately severe disability: unable to walk without assistance, and unable to attend to own bodily needs without assistance. 5 Severe disability: bedridden, incontinent, and requiring constant nursing care and attention. π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ 25

26 ºπ«3 µ «Õ à ß Stroke fast track care maps and protocols 1. æ» µ å ÿã ß å À «ª Õ â«1. Stroke fast track protocol 2. The National Institute of Health Stroke Scale (0-42) (NIHSS) 3. Barthel Index 4. Rankin Scale 5. Stroke discharge summary sheet 2. æ» µ å ßæ ª Õ â«doctorûs order sheet: orders for acute stroke patients 3. æ» µ å» æ ª Õ â«1. Siriraj acute stroke protocol 2. Àπ ß Õ ß µπ Õ «Õß Õ æ π â Ë Õ 3. Dose t-pa (mg) 4. Checklist for intravenous thrombolysis in acute stroke 4. πª «ª Õ â«1. Stroke fast track care map 2. Thrombolysis check list 3. Àπ ß Õ ß «π Õ Ë Õ rt-pa ßÀ Õ Õ πºÿâªé«à Õ Õ Õßµ Õÿ µ π 4. Doctorûs orders sheet 5. NIHSS score sheet (1) 26 π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ

27 µ «Õ à ß Stroke fast track care map and protocol æ» µ å ÿã ß å À «π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ 27

28 æ» µ å ÿã ß å À «µâõß â rt-pa àõπ... π. À Õ «Õ... STROKE FAST TRACK! µ ß «À ºŸâªÉ«Ë â«õ ß stroke Õ à π 3 Ë«ß ËÕºŸâªÉ«... æ» À ß Õ ÿ... ªï HN... «π Ë... æ å R med 2... R neuro 2... R neuro 3... Time Signature Symptoms at onset ÕàÕπ ß π æÿ à µ «Õ Ëπ Ê... Time of arrival Primary doctor Acute stroke Y N Request blood test, CT scan Neurologist Fast track Y N The patient is transfered to CT at History screening for exclusion No Hx of head trauma or stroke within 3 mo No Hx of major Sx or serious trauma within 14 days No Hx of ICH, AVM or aneurysm No Hx of GI or urinary tract hemorrhage within 21 days No Hx of arterial puncture at non compressible site or LP within 7 days No seizure at onset No symptom suggests SAH NIHSS... BP... Laboratory screening for exclusion CT scan result... No evidence of ICH No edema or brain shifting Blood test results BS... PT... PTT... PLT... BS > 50 < 400 mg/dl Plt > 100,000 INR < 1.7 PTT not prolonged Immediate physical examination before rt-pa infusion No rapid spontaneous improvement SBP < 185, DBP < 110 mmhg Consent form is signed NIHSS...BP...DOOR TO NEEDLE TIME... rt-pa Given Y N Departure time from ER Arrival time to stroke unit Total time Thrombolytic is not given Reasons not to use thrombolytic drug Excluded by clinical Minimal neurological deficit Excluded by history Abnormal blood test Spontaneous improve Hemorrhagic stroke Consent form was not signed High blood pressure Delayed processes Note 28 π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ

29 æ» µ å ÿã ß å À «ËÕ... ÿ... HN... The National Institute of Health Stroke Scale (0-42) (NIHSS) Date of examination Level of consciousness Alert 0 Drowsy 1 Stuporous 2 Coma 3 Two questions Õ ÿ Õπ Both correct 0 One correct 1 None correct 2 Two commands À µ µ Õ Õ Obeys both 0 Obeys none 2 Best gaze Õß â π â ß Normal 0 Partial gaze palsy 1 Forced deviation 2 Best visual (visual field) No visual loss 0 Partial hemianopia 1 Complete hemianopia 2 Bilateral hemianopia 3 Facial palsy Normal 0 Minor 1 Partial 2 Complete 3 Best Motor Lt arm π Ëß π 90 Õß» 10 «π No drift 0 Drift 1 Fall in 10 secs 2 No effort against gra 3 No movement 4 Best Motor Rt arm π Ëß π 90 Õß» 10 «π No drift 0 Drift 1 Fall in 10 secs 2 No effort against gra 3 No movement 4 Best Motor Lt leg πõπ 45 Õß» 5 «π No drift 0 Drift 1 Fall in 5 secs 2 No effort against gra 3 No movement 4 Best Motor Rt leg πõπ 45 Õß» 5 «π No drift 0 Drift 1 Fall in 5 secs 2 No effort against gra 3 No movement 4 Limb Ataxia Absent 0 Upper or lower limb 1 Upper & lower limbs 2 Sensory Normal 0 Partial loss 1 Dense loss 2 Neglect No neglect 0 Sensory or visual 1 Sensory & visual 2 Dysarthria Normal articulation 0 Mild to moderate 1 Severe 2 Best language Aphasia No aphasia 0 Mild to moderate 1 Severe 2 Mute 3 Total π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ 29

30 BARTHEL INDEX æ» µ å ÿã ß å À «ON ADMISSION ËÕ... ÿ... HN... WITH HELP INDEPENDENT 1. Feeding Moving from wheelchair to bed and return (includes sitting up in bed) 5 or Personal toilet (wash face, comb hair, shave, clean teeth) Getting on and off toilet (handing clothes, wipe, flush) Bathing self Walking on level surface (if unable propel wheelchair) * Score only if unable to walk 0* 5* 7. Ascend and descend stairs Dressing (includes tying shoes, fastening fasteners) Controlling bowel Controlling bladder 5 10 Total score RANKIN SCALE No symptoms at all 0 No significant disability despite symptoms: able carry out all usual duties and activities. 1 Slight disability: unable to carry out all previous activities but able to look after own affairs without assistance. 2 Moderate disability: requiring some help; but able to walk without assistance. 3 Moderately severe disability: unable to walk without assistance and unable to attend to own bodily needs without assistance. 4 Severe disability: bedridden, incontinent, and requiring constant nursing care and attention 5 30 π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ

31 æ» µ å ÿã ß å À «ËÕ... ÿ... Õ ÿ... HN... Stroke Discharge Summary Sheet Date of admission... Date of discharge... Final Diagnosis Hemorrhagic stroke type... Ischemic Stroke Vessel: Anterior circulation: ACA/MCA Posterior circulation: PCA/VB/AICA/PICA/SCA Cause Emboli : cardiac Type Total anterior circulation infarct Emboli : artery Partial anterior circulation infarct Emboli : unknown Posterior circulation infarct Large vessel thrombosis Lacunar Lacunar stroke : type... Others... Risk of stroke HT AF DM Smoking Alc Dyslipid Others... Complication: Intracerebral hemorrhage Brain edema Others... Other diagnosis CT Investigations Lab: Hct... WBC... PMN...% L...% Eo...% B...% Plt... ESR...mm/hr VDRL... FPG... BUN... Cr... Chol... TG... HDL... LDL... Stool occ bl... CT scan... EKG... MRI not done done scheduled on... MRI brain result... MRA brainresult... MRA neck result... CDUS not done done result... Echocardiogram not done done result... Condition on discharge BP... mmhg Result : improved stable worse dead cause... NIHSS on admission... NIHSS on discharge... Barthel Index... Rankin Scale... Hospital meds... Discharge meds... æ åºÿâµ «... π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ 31

32 æ» µ å ÿã ß å À «ON DISCHARGE ËÕ... ÿ... HN... BARTHEL INDEX WITH HELP INDEPENDENT 1. Feeding Moving from wheelchair to bed and return (includes sitting up in bed) 5 or Personal toilet (wash face, comb hair, shave, clean teeth) Getting on and off toilet (handing clothes, wipe, flush) Bathing self Walking on level surface (if unable propel wheelchair) * Score only if unable to walk 0* 5* 7. Ascend and descend stairs Dressing (includes tying shoes, fastening fasteners) Controlling bowel Controlling bladder 5 10 Total score RANKIN SCALE No symptoms at all 0 No significant disability despite symptoms: able carry out all usual duties and activities. 1 Slight disability: unable to carry out all previous activities but able to look after own affairs without assistance. 2 Moderate disability: requiring some help; but able to walk without assistance. 3 Moderately severe disability: unable to walk without assistance and unable to attend to own bodily needs without assistance. 4 Severe disability: bedridden, incontinent, and requiring constant nursing care and attention 5 32 π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ

33 µ «Õ à ß Stroke fast track care map and protocol æ» µ å ßæ À «À π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ 33

34 æ» µ å ßæ À «À RAMATHIBODI HOSPITAL Department Division Ward ËÕ... Attending Staff Resident H.N... Õ ÿ... ºàπ Ë... DOCTORûS ORDER SHEET Date Hour Date Date Orders for 1 day only Hour Orders for Continuation Hour OFF CBC, PT/INR, PTT BUN/Cr, Electrolytes, glucose Capillary blood glucose 0.9% NSS...ml/h IV drip O2 nasal cannula 2 LPM CT brain without contrast Notify neurology resident on call 12-lead EKG Chest X-ray Please check Foley catheter placement NG tube placement if at high risk of aspiration tpa and post-tpa orders NPO except meds Obtain another IV line (heplock) Keep SBP < 185 and DBP < 110 mmhg May give Nicardipine IV drip Obtain Actilyse (t-pa) (Do not mix until told to do so) Total dose =...mg (0.9 mg/kg, max 90 mg) - 10% of total dose in 1 min - the remaining in 60 min Record BP as follows:- Q15mins 2 hours Q30mins 6 hours Q 1 hour 16 hours Q 4hours if stable Record neuro-signs (GCS) Q 1 hour 24 hours Notify acute stroke on call Neurology resident if BP > 180/110 mmhg or decline in Neuro status or decrease in GCS No arterial puncture No aspirin, aspirin/dipyridamole (Aggrenox ), ticlopidine (Ticlid ), clopidogrel (Plavix ), cilostazole (Pletaal ) heparin, warfarin (Coumadin), Enoxaprarin (Clexane), Nadroparin (Fraxiparine) or any other antithrombotic for first 24 hrs. Post t-pa administration CT scan after t-pa administration 24 hours Sign...code... Admit to Stroke Unit/ICU Dx :... Vitals : Q 4 hours, I/O Activity : Bed rest Head flat (< 30) Fall precaution Aspiration precaution Diet : NPO until cleared by M.D.or swallowing assessment Medications:- - Paracetamol 500 mg po/ng prn pain of fever Q 4 hours - MOM 30 ml po/ng prn constipation QD Sign...code π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ

35 µ «Õ à ß Stroke fast track care map and protocol æ» µ å» æ À «À π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ 35

36 1. «Ë Õ... ºŸâ π... æ» µ å» æ À «À Siriraj Acute Stroke Protocol 2. ß Ë ER «... ºŸâ π æ Õß «... ºŸâ π CBC, BS, electrolyte, BUN, Cr, Coagulogram, INR «... ºŸâ π... (ER physician) 9. Non-contrast CT brain «... ºŸâ π Activate Siriraj acute stroke team «... ºŸâ π... (ER physician) (ER nurse) 4. æ å «ER Ë ª «µ /µ «à ß «... ºŸâ π µ µàõ ß æ å (7308, 7309) «... ºŸâ π... (ER physician) 8. «ª àߺÿâªé«æ ËÕµ «CT brain «... ºŸâ π... (ER nurse) Cerebral infarct Cerebral hemorrhage Stroke mimics æ Àâ π µàõ ªπ È à Àâ æ - Õ π 3 Ë«ß - Õ ÿ >18 ªï - º CT àæ Õ - º Coagulogram ª µ Consent form (Resident/Staff neurology) âπ æ Ë µ À Õ admit µ «À 11. Onset 0-90 π Dose 0.9 mg/kg Àâ 10% iv bolus, 90% iv drip in 1hr «... ºŸâ Àâ... (Resident/Staff neurology on call) 11. Onset π Dose 0.75 mg/kg Àâ 10% iv bolus, 90% iv drip in 1hr «... ºŸâ Àâ... (Resident/Staff neurology on call) 11. Onset π Dose 0.60 mg/kg Àâ 10% iv bolus, 90% iv drip in 1hr «... ºŸâ Àâ... (Resident/Staff neurology on call) 12. ºŸâªÉ«admit Ë Siriraj Acute Stroke Unit (8613, 8614) «... ºŸâ π... (Stroke unit nurse) âß neurosurgeon ««à ºŸâªÉ«â thrombolysis admit Ë Word (Resident/Staff neurology on call) * À Àµÿ πõ «Àâ by pass ºŸâÕ π«πõ «µ µàõºÿâõ π«ßæ» (». π.æ.ª Ï «π ) µ ß 36 π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ

37 æ» µ å» æ Àπ ß Õ ß µπ Õ «Õß Õ æ π â Ë Õ À⺟âªÉ«À ÕºŸâ Õ π πºÿâªé«ªìπºÿâ Õ âõ «ËÕßÀ / π àõß Àπ ß Õ π È â æ â π /π ß/π ß «...Õ ÿ... ªï µ ª µ «ª π µ â µ æπ ß π «À Ë... ß... π π ªìπ ºŸâªÉ«ºŸâ Õ π π π π... ÕߺŸâªÉ«ËÕ π /π ß/π ß «... H.N....A.N.... â æ â â ß Õ Õß «Õß Õ æ π Àâ Ë Õ ßÀ Õ Õ æ å Õß æ» µ å» æ ßµàÕ ªπ È âõ 1 Àâ Ë Õ πºÿâªé««õß Õ æ π π 3 Ë«ß À⺟âªÉ«Õ Ë øóôπµ ««æ Ÿß «à ÿà Ë à â ª 30% âõ 2 â æ â â âõ àß È Õ Õß ß à «â ßµâπ «Èß ßº âõπ Õß â π È Õ 2.1 «Õ ÕÕ π Õß Õ ÕÕ π «µà ß Ê Õß à ß Õ µ Ë ß Õß âõ âõππ Ȫ 7% 2.2 Õ µ æâ π ÿπ ß (Anaphylactic, Angioedema) ª 0.1% ºŸâ Àâ âõ Ÿ ß ËÕ... ß ËÕ... (...) (...) µ Àπàß... ºŸâªÉ«/ ºŸâ Õ π πºÿâªé«ß ËÕ...æ π ß ËÕ...æ π (...) (...) µ Àπàß... µ Àπàß... «π Ë.../.../... «...π. π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ 37

38 æ» µ å» æ À «À BODY WEIGHT (KG) Dose t-pa (mg) Onset 0-90 min min min. 0.9 (mg/kg) 0.75 (mg/kg) 0.6 (mg/kg) π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ

39 æ» µ å» æ À «À Sticker ËÕºŸâªÉ«Checklist for intravenous thrombolysis in acute stroke Initial assessment Onset of stroke clearly established < 3 hours prior to presentation Unequivocal diagnosis of stroke; no seizure at onset Urgent blood work (Blood glucose, CBC, electrolyte, Coagulogram, INR) Emergency non-contrast CT brain Acute Stroke Team notified Urgently request family members to be present ECG Consider insert urinary catheter and NG tube prior to thrombolysis CT assessment Non-contrast CT assessment within 3 hours of stroke No signs of neoplasm, SAH or aneurysm Final assessment At least moderate deficit remaining (NIHSS > 4) 2 nd canula inserted BP below 185/110, may give a single dose of i.v. metoprolol or nicardipine if required 2.7 < blood sugar level < 22 Platelet count > 100,000/mm3, INR < 1.7, normal APTT No suspicion of septic emboli, SAH or pregnancy at present time No previous intracranial haemorrhage/sah, cerebral neoplasm No AMI, stroke or head trauma in previous 3 months No history of haemorrhage in previous 30 days, that might lead to unmanageable haemorrhage with TPA Patient or responsible person provide informed consent (specific information sheet and consent form for rtpa) π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ 39

40 æ» µ å» æ À «À Date Time 1A Consciousness 0=Alert 1=Sleepiness 2=Stupor 3=Coma 1B Question 0 = Answers both questions 1 = Answers only one question 2 = Answers neither question 1C Commands 0 = Performs both tasks 1 = Performs only one task 2 = Performs neither task 2 Gaze 0=Normal 1 = Partial gaze plasy 2 = Total gaze palsy 3 Visual field 0 = No visual loss 1 = Partial hemianopsia 2 = Total hemianopsia 3 = Bilateral hemianopsia 4 Facial Palsy 0 = Without facial paralysis 1 = Minor facial paralysis 2 = Partial facial paralysis 3 = Complete facial paralysis 5 Arm Strength 0=Normal 1 = Drifts down after 10 seconds 2 = Fall before 10 seconds 3 = No effort against gravity 4 = No movement 9 = Limb amputated 6 Leg Strength 0=Normal 1 = Drifts down after 5 seconds 2 = Fall before 5 seconds 3 = No effort against gravity 4 = No movement 9 = Limb amputated 7 Ataxia 0 = Does not present ataxia 1=Ataxia in only one limb 2=Ataxia in 2 limbs 9 = Limb amputated 8 Sensory 0 = Without sensory alteration 1 = Mild to moderate sensory loss 2 = Severe or complete sensory loss 9 Language 0 = Without language alteration 1 = Mild to moderate aphasia 2 = Severe aphasia 3 = Mute or global aphasia 10 Dysarthria 0 = Without dysarthria 1 = Mild or moderate dysarthria 2 = Severe dysarthria or anarthria 9=Intubation 11 Inattention 0 = Without inattention 1 = Mild inattention 2 = Severe inattention Total Signature Left Left Left Left Right Right Right Right Left Left Left Left Right Right Right Right 40 π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ

41 æ» µ å» æ À «À Inclusion and Exclusion Criteria of the National Institute of Neurological Disorders and Stroke (NINDS) study* Inclusion Criteria of NINDS Ischemic stroke of defined onset < 3 hours Deficit measurable on NIHSS Baseline CT of the brain without evidence of hemorrhage Exclusion Criteria of NINDS A prior stroke within the last 3 months prior to presentation (PTP) Major surgery within the last 14 days PTP Serious head trauma within the last 3 months PTP History of intracranial hemorrhage (ICH) Systolic blood pressure (BP) > 185 mmhg or diastolic BP >110 mmhg or if aggressive treatment was required to lower the BP to below these limits Rapidly improving or minor symptoms Symptoms suggestive of subarachnoid hemorrhage (SAH) Gastrointestinal bleeding or urinary tract hemorrhage within the 3 weeks PTP Arterial puncture at a non-compressible site within the last 7 days PTP Seizure at the onset of symptoms Anticoagulants or heparin within 48 hours before stroke onset or elevated PTT (patial thromboplastin time), or elevated PT (prothrombin time) > 15 sec Platelet count < 100,000/ml Blood glucose < 50 mg/dl or above 400 mg/dl *Tissue Plasminogen Activator for Acute Ischemic Stroke CT, computed tomography; NIHSS, National Institutes of Health Stroke Scale; NINDS, National Institute of Neurological Disorders and Stroke The National Institute of Neurological Disorders and Stroke rt-pa Stroke Study Group. N Engl J Med 333(24): , π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ 41

42 42 π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ

43 µ «Õ à ß Stroke fast track care map and protocol πª «æ å «ß ÿ π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ 43

44 πª «æ å STROKE FAST TRACK CARE MAP DATE TIME AT ARRIVAL NAME AGE HN AN Department/ Emergency department Emergency department Intensive care unit Aspect of (preliminary evaluation) (thrombolytic therapy) care Assessment Labs & Tests Medication & Intervention Nursing intervention 1. Record TIME AT ONSET 2. Check vital signs once & BP q 15 min. 3. Assess NIHSS 4. Check inclusion & exclusion criteria 1. Stat blood draw for CBC, PT, aptt, BS 2. Stat non-contrast CT scan of brain TIME AT CT SCAN 1. IV assess NSS keep at rate 40 cc/hr 2. No antiplatelet & anticoagulant agent 3. Avoid of urinary catheterization and nasogastric tube insertion 1. Activate stroke fast track pathway 2. Record vital signs once & BP q 15 min. 3. Immediately follow doctorûs order 1. Record results of CT scan & labs 2. Check vital signs & neuro signs (in NIHSS sheet) 3. q 15 min. for 2 hrs 4. If SBP > 185 or DBP > 110 mmhg, go to elevated BP treatment sheet 5. Record patient weight in kg 1. Stat stool occult blood (bed side kit) 1. Second IV assess : NSS lock in opposite arm 2. Prepare IV rt-pa (concentration 1 mg : 1 cc) 3. Total dose : mg (0.9 mg/kg, max dose 90 mg) Administer mg (10% of total dose) IV over 1min. Administer mg (90% of total dose) IV infusion over 60 min. TIME AT NEEDLE 4. Transfer to ICU TIME TO ICU 5. Avoid arterial punctures, frequent venous punctures and urinary catheterization for 24hrs post rt-pa 6. No antiplatelet & anticoagulant agent for 24 hrs post rt-pa 1. Record vital signs & neuro signs q 15 min. for 2 hrs post rt-pa 2. Notify physicians for SBP > 185 & DBP > 110 mmhg Nutrition NPO NPO NPO Activity Bed rest Strict bed rest Strict bed rest 1. Continue previous monitor of vital signs and neuro signs q 15 min until 2 hrs then q 30 min. for 6 hrs then 60 min. for 16 hrs 2. If suspect for intracranial hemorrhage go to ICH management sheet 3. If SBP > 185 or DBP > 110 mmhg, go to elevated BP treatment sheet 4. Cardiac monitoring (if needed) 5. Check input & output 1. After 24 hrs CT scan to exclude intracranial hemorrhage if hemorrhage present go to ICH management sheet 1. Continue rt-pa infusion then IV NSS at rate 60 cc/hr 2. Oxygen canula (if needed) 3. No antiplatelet & anticoagulant agent for 24 hrs post rt-pa 4. Peptic ulcer prophylaxis (H2-blocker/ Proton pump inhibitor) 5. Continue patientûs regular medication prescribed (if appropriated) 1. Check bleeding & hematoma from puncture sites, check urine, stool emesis or others for blood 2. Notify physicians immediately for evidence of bleeding neurological deterioration SBP > 185 or < 100 mmhg DBP > 105 or < 60 pulse < 50/min * respiration > 24/min 44 π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ

45 πª «æ å THROMBOLYSIS CHECK LIST Name Age HN AN Date: Attending staff Time: Symptom Onset rtpa given: NIHSS INCLUSION criteria (must all be YES) * Age 18 years or older Yes No * Time of onset well established to be less than 3 hours Yes No * Clinical diagnosis of ischemic stroke causing a measurable neurological deficit Yes No * CT without hemorrhage or significant edema Yes No EXCLUSION criteria (must all be NO) * SBP > 185 or DBP > 110 Yes No * Symptoms rapidly improving or minor symptoms (NIHSS = 0-6) Yes No * Coma or severe obtundation (or NIHSS > 25) Yes No * Seizure at onset Yes No * Symptoms of subarachnoid hemorrhage (diffuse headache, stiffness of neck) Yes No * Prior stroke or head trauma within 3 months Yes No * Major surgery within 14 days Yes No * Prior intracranial hemorrhage Yes No * GI hemorrhage or urinary tract hemorrhage within 21 days Yes No * Arterial puncture at a noncompressible site or LP within 7 days Yes No * Recent Myocardial infarction Yes No * Patients receiving heparin within 48 hrs and with an elevated PTT Yes No * PT >15 or INR > 1.7 Yes No * Platelet count < 100,000 Yes No * Plasma glucose < 50 or > 400 Yes No * Hematocrit < 25% Yes No * Pregnant (Note: menstruation is NOT a contraindication) Yes No TREATMENT Total dose to be given (0.9mg/kg) Weight (kg): x 0.9 mg = mg (maximum 90 mg) Give 10% bolus over 1 minute mg (= ml) Give remaining 90% constant infusion over 60 minutes mg (= ml)...m.d. Physicianûs Signature π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ 45

46 πª «æ å Àπ ß Õ ß «π Õ Ë Õ rt-pa ßÀ Õ Õ πºÿâªé«à Õ Õ Õßµ Õÿ µ π ÿà ß πª «πª ««π Ë... Õπ...æ.».... À Õ Õ Õßµ À ÕÕÿ µ π æ π â«àâ Ë Õ ßÀ Õ Õ ªìπ µ π Ë â π ºŸâªÉ«Õ Ë â π 3 Ë«ß π µ Èß µà Ë Õ π ß Ë Àâ ß ÿà ß πª «Õ È ßª πå «âõπ ËÕ Èπ Ë Õ ßÀ Õ Õ ßπ È ª πå Ë â» æ «à ºŸâªÉ«Ë â Ë Õ 31-50% Õ Èπ À ß â 24 Ë«ß Õ Õ ªìπª µ «3 Õπ À ß â ÿà Ë à â Àâ Õ Èπ À ß 24 Ë«ß À Õ Õ Õ ª µ Ë 3 Õπ æ ß à 20-30% «âõπ ËÕ Èπ» æ «à ºŸâªÉ«Õ «âõπõ Ëπ Ê â à «Õ ÕÕ π Õß â 6.4% «ß «âõπõ Ëπ Ê â à «Õ ÕÕ Ë à ß à«πõ Ëπ Ê æâ µàõ à ß Áµ Õ «ºŸâªÉ«Ë À Á à«õ «âõπ â Àπ ß Õ ß «π Õ π È â æ â...ºÿâªé«à ÕºŸâÕπÿ µ* ( «æ π å ºŸâªÉ«ªìπ... ÕߺŸâªÉ«ËÕ...) HN... âõà π µ «Õ Ÿ Õ Ë â«π â«õ π Õ Àâ Ë Õ ßÀ Õ Õ À Àµÿ «ÿ Õ π «âõπ â æ â à Õ ªìπ «º Õß ÿà ß πª «πª «à âõßà ÕøÑÕß âõß π π ÿ à«π µâπ ß Õß πª «µàõ à ß æ âõ ππ È â ß Õ ËÕ «â ªìπÀ π à π Õ Àâ Ë Õ ßÀ Õ Õ ß ËÕ...ºŸâ π Õ */ºŸâ à π Õ * (...) «Ë «âõß ªìπ... ÕߺŸâªÉ«* ß ËÕ...æ π (...) ß ËÕ...æ π (...) «π Ë... Õπ...æ.» π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ

47 Doctorûs orders πª «312 ππ «µ « DATE ONE DAY DATE CONTINUATION - Check vital & neuroûs signs after infusion q 15 mins. for 2 hrs then q 30 mins. for 6 hrs then q 60 mins. until 24 hrs - Maintain BP 185/110 mmhg, if BP out of ranges please notify - Avoid after infusion insertion Foley catheter within 2 hrs insertion NG tube within 24 hrs entral venous access, arterial puncture & intramuscular injection - UA, Stool occult blood If hemorrahage is suspected 1. Stop infusion of the thrombolytic drug. 2. Repeat CBC, platelet, INR, PTT, PT (fibrinogen, D-dimer) 3. CT brain stat 4. Prepare for administration of 6 to 8 FFP 5. Notify neurosurgeon - NPO except meds for 24 hrs - Bed rest - Record I/O - Medication 1. H 2 blocker/ppi Prophylaxis µ ËÕ... π ÿ... Õ ÿ... HN... Diagnosis æâ µ ËÕ... π ÿ... Õ ÿ... HN... Diagnosis æâ µ ËÕ... π ÿ... Õ ÿ... HN... Diagnosis æâ π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ 47

48 πª «æ å NIHSS SCORE SHEET (1) Patient Name Unit # Date / / TOTAL Date/Time of Stroke Onset Stroke Type Examiner DATE/SCORE NIHSS ITEM SCORE DEFINITIONS 1a. Level of 0 = Alert and responsive Consciousness 1 = Response to minor stimuli 2 = Response to painful stimuli 3 = Reflex response or unresponse 1b. Questions 0 = Both correct ask ptûs age 1 = One correct and month 2 = Neither correct 1c. Commands 0 = Both correct open/close eyes 1 = One correct grip/release hand 2 = Neither correct 2. Best Gaze 0=Normal horizontal EOM by 1 = Partial gaze palsy voluntary or Dollûs 2 = Forced eye deviation total paresis 3. Visual Field 0=No visual loss R/L field of good eye 1 = Partial hemianopia, 2 = Complete hemianopia 3 = Bilateral hemianopia 4. Facial Palsy 0=Normal R/L check symmetry of 1 = Minor paralysis (flat NLF) grimace to pain. 2 = Partial paralysis (UMN) 3 = Complete paralysis (U & LMN) 5. Motor Arm 0 = No drift R arms outstretched 1 = Drift 90*(sitting) or 2 = Some antigravity effort 45*(supine) for 10 secs. 3 = No antigravity effort L 4=No movement at all X = Unable to assess (amputation) 6. Motor Leg 0 = No drift R raise leg to 30* 1 = Drift (supine) for 5 secs. 2 = Some antigravity effort 3 = No antigravity effort L 4=No movement at all X = Unable to assess (amputation) 7. Limb Ataxia 0=No ataxia R/L finger to nose 1 = Ataxia in upper or lower ext. or heel to shin 2 = Ataxia in upper & lower ext. X = Unable to assess (amputation) 8. Sensory 0=Normal R/L only stroke-related loss 1 = Mild-mod unilateral loss 2 = Total loss, Coma, bilateral loss 9. Best Language 0=Normal name objects, 1 = Mild-mod aphasia read sentences, 2 = Severe aphasia writing 3 = Mute, global aphasia, coma 10. Dysarthria 0=Normal 1=Mild-mod; slurred 2 = Severe; unintelligible or mute X=Intubation 11. Extinction/Neglect 0=Normal simultaneous touch & 1 = Neglect to double simultaneous visual field test stimulation in any modality 2 = Both neglect TOTAL SCORE 48 π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ

49 ºπ«4 CT scan examples for early signs of cerebral ischemia 12 Ÿª Ë 1 Hyperdense MCA sign (arrow). Ÿª Ë 2 Loss of the anterior half of the insular ribbon (arrow). π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ 49

50 Ÿª Ë 3 Loss of the insular ribbon on the right side (arrows) and hypodensity of the basal ganglia (short arrows). Ÿª Ë 4 Sulcal effacement right frontal lobe (arrow). 50 π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ

51 Ÿª Ë 5 Early signs of a > 2/3 MCA infarction. This patient should not be treated with thrombolysis π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ 51

52 ºπ«5 Stroke Unit 13 Stroke unit À «À Ë«ªÀ ß «Ë ªìπ à«π Ÿ ºŸâªÉ«À Õ Õ Õß ª ª π Ÿ ºŸâªÉ«À«æ æ åºÿâ Ë «æ ß æ âõ Èß æ æ ß À«æ Ë «Ÿâ «π Ÿ ºŸâªÉ«À Õ Õ Õß πõ π È ßµâÕß ª ÿ ª À Õ À«à ß À«æ ºŸâªÉ«µ Õ à ß Ë Õ Õß stroke unit π â ªìπ 3 Õ 1. Acute stroke unit 2. Rehabilitation stroke unit 3. Combined stroke unit Õß stroke unit ß à «â ßµâπ ßæ µà ß Ê stroke unit π Á â æ ËÕ «ÿâ à Õß µ Èß stroke unit «Àâ π«π µ ß ÈπµË 4 µ ß æ 1 πµàõºÿâªé«2 µ ß ÿ ±å ËÕß Õ æ å «ÿõÿª å À stroke unit π«πàπà«àµÿº «ªìπ Õß Stroke unit 1 ËπÕπ 2 À ªŸ ÕߺŸâªÉ«À Õ Õ Õß Ë à à«à Õµ «Õß â ªÑÕß π º 2 Infusion pump 4 æ ËÕ «ÿ Àâ πè ßÀ Õ Õ Àâ àπ ªÑÕß π «º æ ËßÕ ªìπÕ πµ ß «µ â 3 Syringe pump 0-1 «ÿ Àâ πè πª πâõ ªÑÕß π «º æ π Ë Õ πµ Ÿß 4 ËÕß defibrillation 1 æ ËÕ â π à««µºÿâªé«ë µâπà «º ª µ 5 ËÕß «ÿ ÀâÕ À À «0-1 æ ËÕ â π «ÿ ÀâÕ À À «πºÿâªé«ë ªí À π àõ Õ À 6 Ambu bag 4 æ ËÕ â π Õ â ªÕ ºŸâªÉ«π À«à ß à«à Õ À À Õ Ÿ À 7 ËÕß«πÈ µ π Õ ª π È«2 æ ËÕµ ««πè µ π Õ ª µ ߺŸâªÉ«π àß à«π 8 Pad slide 1 À ËÕπ â ºŸâªÉ«9 Monitor 0-1 æ ËÕµ µ æ 52 π«ß À Õ Õ Õßµ Õÿ µ π â«ë Õ ßÀ Õ Õ

Stroke Transfer Checklist

Stroke Transfer Checklist Stroke Transfer Checklist When preparing to transfer an acute stroke patient to the UF Health Shands Comprehensive Stroke Center, please make every attempt to include the following information: Results

More information

«ÿ Õß â πºÿâªé«à«π π Ë 2 π π À«π ßæ æ ß π æ ÿ æ ÿà ß π «ªØ μ Õ «ÿ π ßæ æ ß π Õ.æ ß π. π

«ÿ Õß â πºÿâªé«à«π π Ë 2 π π À«π ßæ æ ß π æ ÿ æ ÿà ß π «ªØ μ Õ «ÿ π ßæ æ ß π Õ.æ ß π. π The Prevalence of Depression among Type 2 Diabetic Patients π æπ åμâπ Original Article π π À«π ßæ æ ß π ÿà ß π «ªØ μ Õ «ÿ π ßæ æ ß π Õ.æ ß π. π The Prevalence of Depression among Type 2 Diabetic Patients

More information

μ π«ß ÿμ Ÿ πºÿâªé«ÿà Õ À Õ Õ À «æ π

μ π«ß ÿμ Ÿ πºÿâªé«ÿà Õ À Õ Õ À «æ π S68 ßæ (ª» ) π æπ åμâπ : ß â μ π«ß ÿμ Ÿ πºÿâªé«ÿà Õ À Õ Õ À «æ π The Rationale to Guideline of Treatment for Secondary Prevention in Patients with Acute Coronary Syndromes π «ÿ Õ æ æå,..*; πμ ÿ Ÿ å, Pharm.D.,

More information

ACCESS CENTER:

ACCESS CENTER: ACCESS CENTER: 1-877-367-8855 Emergency Specialty Services: BRAIN ATTACK Criteria: Stroke symptom onset time less than 6 hours Referring Emergency Department Patient Information Data: Time last known normal:

More information

Thrombolysis for acute ischaemic stroke Rapid Assessment Protocol NORTHERN IRELAND Regional Protocol (Version 002 July 08)

Thrombolysis for acute ischaemic stroke Rapid Assessment Protocol NORTHERN IRELAND Regional Protocol (Version 002 July 08) Thrombolysis for acute ischaemic stroke Rapid Assessment Protocol NORTHERN IRELAND Regional Protocol (Version 002 July 08) Patient Details Time of onset? Capillary Blood glucose 2.8-22.2 mmol/l? Blood

More information

Thrombolysis Assessment

Thrombolysis Assessment Thrombolysis Assessment Brief Clinical Summary of symptom onset of arrival of patient of assessment BP GCS BM If BM

More information

âà«à à æ π åÿ À à 2009 π Á Ë â π ßæ À

âà«à à æ π åÿ À à 2009 π Á Ë â π ßæ À 27 âà«à à æ π åÿ À à 2009 π Á Ë â π ßæ À π ÀÕ À«æ.. ÿà ß π ÿ «ßæ À π æπ åμâπ Abstract Hospitalized Pediatric Patients with Influenza A (H1N1) in Mahasarakham Hospital Homhuan C. Departmont of Pediatric,

More information

Siriraj Cancer Center

Siriraj Cancer Center π«áß» Siriraj Cancer Center 2543-2544 Õ.πæ. æ πå π µπå Õß 2545-2546».πæ. æ ÿ«õß 1 µ.. 2546 - ªí ÿ π Õß».πæ.» º «ß»å».æ. «æ æ ÿ«π ß π Õ æ µ Èπ 13 ÀâÕß 1321» æ å 0-2419-7000 µàõ 4471-2, 0-2412-1360 0-2412-9169

More information

ED Stroke Panel Page 1 of 2

ED Stroke Panel Page 1 of 2 ED Stroke Panel Page 1 of 2 Reference EMMC *************************Usec: Call Operator to page a Stroke Alert ********************** Laboratory Bedside Glucose Monitoring ONCE Notify provider if glucose

More information

μâπ ÿπ-ª º Õß â Ë Õ tenecteplase (TNK) ª streptokinase (SK) π À Õ Õ À «π ST-elevated myocardial infarction (STEMI)

μâπ ÿπ-ª º Õß â Ë Õ tenecteplase (TNK) ª streptokinase (SK) π À Õ Õ À «π ST-elevated myocardial infarction (STEMI) 173 π æπ åμâπ μâπ ÿπ-ª º Õß â Ë Õ tenecteplase (TNK) ª streptokinase (SK) π À Õ Õ À «π ST-elevated myocardial infarction (STEMI) Õ Ï» ÿ μ æ.., «..*, ÿ ß à ß æ..**, æ à μ æ..**, ÿ«μ Èß«æ æß»å æ..**, ß Œß»

More information

Primary Stroke Center Acute Stroke Transfer Guidelines When to Consider a Transfer:

Primary Stroke Center Acute Stroke Transfer Guidelines When to Consider a Transfer: When to Consider a Transfer: Hemorrhagic Stroke Large volume intracerebral hematoma greater than 5cm on CT Concern for expanding hematoma Rapidly declining mental status, especially requiring intubation

More information

newsletters æ åº «Àπ ß Ààߪ» π π»π ªï Ë 15 Ë 1 Æ 2552 μ «à ßÕ Àâ πõ æ Ë ÈπÕ ß ËÕπ μ π ª ß 31 μÿ 2552 vote àß ß â à æ π Àπâ π

newsletters æ åº «Àπ ß Ààߪ» π π»π ªï Ë 15 Ë 1 Æ 2552 μ «à ßÕ Àâ πõ æ Ë ÈπÕ ß ËÕπ μ π ª ß 31 μÿ 2552 vote àß ß  â à æ π Àπâ π π π»π...1 Journal Watch...2 π π μ Õ æ À à...5 Àπ ª ÿ «ª ªï 2552-2553...6 ª «æ Õ ß«πß πª ÿ À à 52...7 newsletters ªï Ë 15 Ë 1 Æ 2552 æ åº «Àπ ß Ààߪ» «à æ åº «Àπ ß Ààߪ» «ºà π ªÕ à ß «Á«μÕππ È Áºà π ª π

More information

Protocol for IV rtpa Treatment of Acute Ischemic Stroke

Protocol for IV rtpa Treatment of Acute Ischemic Stroke Protocol for IV rtpa Treatment of Acute Ischemic Stroke Acute stroke management is progressing very rapidly. Our team offers several options for acute stroke therapy, including endovascular therapy and

More information

o Unenhanced Head CT

o Unenhanced Head CT Drip & Ship Protocol Acute Stroke Ready Hospital (ASRH) Duluth Area Primary Stroke Center (St. Luke s & St. Mary s Essentia) PATIENT LABEL Patient displays strokelike symptoms EMS/ED CSS > 0 Glucose >

More information

what do the numbers really mean? NIHSS Timothy Hehr, RN MA Stroke Program Outreach Coordinator Allina Health

what do the numbers really mean? NIHSS Timothy Hehr, RN MA Stroke Program Outreach Coordinator Allina Health what do the numbers really mean? NIHSS Timothy Hehr, RN MA Stroke Program Outreach Coordinator Allina Health NIHSS The National Institutes of Health Stroke Scale (NIHSS) is a tool used to objectively quantify

More information

Page 1 of 7. Intraparenchymal hemorrhage or subarachnoid hemorrhage. Consult neurosurgery

Page 1 of 7. Intraparenchymal hemorrhage or subarachnoid hemorrhage. Consult neurosurgery Management of Acute Ischemic Stroke in Adult Patients INITIAL ASSESSMENT Look for signs and symptoms of stroke (see Appendix A) STAT finger stick glucose STAT 12-lead EKG Inform radiology that patient

More information

AGWS Stroke Thrombolysis Clinical Profoma

AGWS Stroke Thrombolysis Clinical Profoma AGWS Stroke Thrombolysis Clinical Profoma Incorporating Salisbury NHS Foundation Trust guidance Date: On Arrival: Affix patient label here) GCS NIHSS Score: Pulse SaO on Air Give O only if < 95 % on Air

More information

Thrombolysis administration

Thrombolysis administration Thrombolysis administration Liz Mackey Stroke Nurse Practitioner Western Health Sunshine & Footscray Hospital, Melbourne Thanks ASNEN committee members Skye Coote, Acute Stroke Nurse, Eastern Health (slide

More information

GUIDELINES FOR THE EARLY MANAGEMENT OF PATIENTS WITH ACUTE ISCHEMIC STROKE

GUIDELINES FOR THE EARLY MANAGEMENT OF PATIENTS WITH ACUTE ISCHEMIC STROKE 2018 UPDATE QUICK SHEET 2018 American Heart Association GUIDELINES FOR THE EARLY MANAGEMENT OF PATIENTS WITH ACUTE ISCHEMIC STROKE A Summary for Healthcare Professionals from the American Heart Association/American

More information

ß πºÿâªé«: «â π ÈÕÀ «º ª µ À«à ßµ Èß å À ÕÀ ß Õ A case report : Peripartum cardiomy opathy

ß πºÿâªé«: «â π ÈÕÀ «º ª µ À«à ßµ Èß å À ÕÀ ß Õ A case report : Peripartum cardiomy opathy «ß πºÿâªé«: «â π ÈÕÀ «º ª µ À«à ßµ Èß å À ÕÀ ß Õ A case report : Peripartum cardiomy opathy Õ ÈÕæß»å ªæπ * Uaepong Limpapasit* àõ «â π ÈÕÀ «º ª µ À«à ßµ Èß åà ÕÀ ß Õ Peripartum cardiomyopathy ªìπ «Ëæ â

More information

Canadian Stroke Best Practices Initial ED Evaluation of Acute Stroke and Transient Ischemic Attack (TIA) Order Set (Order Set 1)

Canadian Stroke Best Practices Initial ED Evaluation of Acute Stroke and Transient Ischemic Attack (TIA) Order Set (Order Set 1) Canadian Best Practice Recommendations for Stroke Care: All patients presenting to an emergency department with suspected stroke or transient ischemic attack must have an immediate clinical evaluation

More information

NURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE PROTOCOLS. ACUTE CEREBROVASCULAR ACCIDENT TPA (ACTIVASE /alteplase) FOR THROMBOLYSIS

NURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE PROTOCOLS. ACUTE CEREBROVASCULAR ACCIDENT TPA (ACTIVASE /alteplase) FOR THROMBOLYSIS NURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE PROTOCOLS ACUTE CEREBROVASCULAR ACCIDENT TPA (ACTIVASE /alteplase) FOR THROMBOLYSIS I. Purpose : A. To reduce morbidity and mortality associated

More information

NIHSS. Category Scale Definition Date/Time Date/Time Date/Time. Score Initial. Drip & Ship Protocol. Initials: Signature: Initials: Signature:

NIHSS. Category Scale Definition Date/Time Date/Time Date/Time. Score Initial. Drip & Ship Protocol. Initials: Signature: Initials: Signature: NIHSS 1a. Level of Consciousness (Alert, drowsy, etc.) Category Scale Definition Date/Time Date/Time Date/Time 1b. LOC Question (Month, age) 1c. LOC Commands (Open, close eyes, make fist, let go) 2. Best

More information

Unclogging The Pipes. Zahraa Rabeeah MD Chief Resident February 9,2018

Unclogging The Pipes. Zahraa Rabeeah MD Chief Resident February 9,2018 Unclogging The Pipes Zahraa Rabeeah MD Chief Resident February 9,2018 Please join Polleverywhere by texting: ZRABEEAH894 to 37607 Disclosures None Objectives Delineate the differences between TPA vs thrombectomy

More information

PATIENT S NOTES History and Physical Brain Attack Stroke

PATIENT S NOTES History and Physical Brain Attack Stroke UNIVERSITY HOSPITALS OF CLEVELAND PATIENT S NOTES History and Physical Brain Attack Stroke 040527.01 page 1 of 8 Name Hospital # Date Sex Age Dr. Service Division Rm No Date and Time: Current inpatient

More information

Catheter-Associated Urinary Tract Infection

Catheter-Associated Urinary Tract Infection Catheter-Associated Urinary Tract Infection Somwang Danchaivijitr MD*, Chertsak Dhiraputra MD **, Rachada Cherdrungsi MSc***, Duangporn Jintanothaitavorn MSc***, Nitaya Srihapol RN*** *Department of Medicine,

More information

Patient Care Orders for CODE STROKE: alteplase Administration order set for Acute Ischemic Stroke less than 4.5 hours

Patient Care Orders for CODE STROKE: alteplase Administration order set for Acute Ischemic Stroke less than 4.5 hours Allergy Alert: NO YES (Refer to Care-Area Administrative Data Screen in MEDITECH) Orders: The prescriber must check the tick box or complete the blank to activate the order. Any changes to be initialled

More information

Emergency Room Procedure The first few hours in hospital...

Emergency Room Procedure The first few hours in hospital... Emergency Room Procedure The first few hours in hospital... ER 5 level Emergency Severity Index SOP s for Stroke Stroke = Level 2 Target Time = 1 Hour 10 min from door 2 Doctor 25 min from door 2 CT 60

More information

ENCHANTED Era: Is it time to rethink treatment of acute ischemic stroke? Kristin J. Scherber, PharmD, BCPS Emergency Medicine Clinical Pharmacist

ENCHANTED Era: Is it time to rethink treatment of acute ischemic stroke? Kristin J. Scherber, PharmD, BCPS Emergency Medicine Clinical Pharmacist ENCHANTED Era: Is it time to rethink treatment of acute ischemic stroke? Kristin J. Scherber, PharmD, BCPS Emergency Medicine Clinical Pharmacist Pharmacy Grand Rounds 26 July 2016 2015 MFMER slide-1 Learning

More information

Emergency Department Management of Acute Ischemic Stroke

Emergency Department Management of Acute Ischemic Stroke Emergency Department Management of Acute Ischemic Stroke R. Jason Thurman, MD Associate Professor of Emergency Medicine and Neurosurgery Associate Director, Vanderbilt Stroke Center Vanderbilt University,

More information

Stroke Update. Lacunar 19% Thromboembolic 6% SAH 13% ICH 13% Unknown 32% Hemorrhagic 26% Ischemic 71% Other 3% Cardioembolic 14%

Stroke Update. Lacunar 19% Thromboembolic 6% SAH 13% ICH 13% Unknown 32% Hemorrhagic 26% Ischemic 71% Other 3% Cardioembolic 14% Stroke Update Michel Torbey, MD, MPH, FAHA, FNCS Medical Director, Neurovascular Stroke Center Professor Department of Neurology and Neurosurgery The Ohio State University Wexner Medical Center Objectives

More information

Journal Club. 1. Develop a PICO (Population, Intervention, Comparison, Outcome) question for this study

Journal Club. 1. Develop a PICO (Population, Intervention, Comparison, Outcome) question for this study Journal Club Articles for Discussion Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-pa Stroke Study Group. N Engl J Med. 1995 Dec

More information

Updated Ischemic Stroke Guidelines นพ.ส ชาต หาญไชยพ บ ลย ก ล นายแพทย ทรงค ณว ฒ สาขาประสาทว ทยา สถาบ นประสาทว ทยา กรมการแพทย กระทรวงสาธารณส ข

Updated Ischemic Stroke Guidelines นพ.ส ชาต หาญไชยพ บ ลย ก ล นายแพทย ทรงค ณว ฒ สาขาประสาทว ทยา สถาบ นประสาทว ทยา กรมการแพทย กระทรวงสาธารณส ข Updated Ischemic Stroke Guidelines นพ.ส ชาต หาญไชยพ บ ลย ก ล นายแพทย ทรงค ณว ฒ สาขาประสาทว ทยา สถาบ นประสาทว ทยา กรมการแพทย กระทรวงสาธารณส ข Emergency start at community level: Prehospital care Acute stroke

More information

Áߪ Ÿ. «Ÿµ π æ å Ààߪ» «æ æ å Ààߪ» ß Áß«Ààߪ» Áßπ «Áß«Ààߪ» å«ààߪ» π Áß Ààß µ æ å Æ 2550

Áߪ Ÿ. «Ÿµ π æ å Ààߪ» «æ æ å Ààߪ» ß Áß«Ààߪ» Áßπ «Áß«Ààߪ» å«ààߪ» π Áß Ààß µ æ å Æ 2550 «Ÿµ π æ å Ààߪ» «æ æ å Ààߪ» ß Áß«Ààߪ» Áßπ «Áß«Ààߪ» å«ààߪ» π Áß Ààß µ æ å Æ 2550 ISBN 978-974-422-419-4 π æ æå ÿß æ «3/3 ÿ ÿ «49 «ß Õßµ π Àπ Õ µ«π ÿß æœ 10110» æ å 0-2662-4347 0-2258-7954 E-mail: bkkmed@gmail.com

More information

Acute Stroke Protocols Modified- What s New in 2013

Acute Stroke Protocols Modified- What s New in 2013 Acute Stroke Protocols Modified- What s New in 2013 KUMAR RAJAMANI, MD, DM. Vascular Neurologist-MSN Associate Professor of Neurology WSU School of Medicine. Saturday, September 21, 2013 Crystal Mountain

More information

SARASOTA MEMORIAL HOSPITAL. NURSING PROCEDURE NATIONAL INSTITUTE OF HEALTH STROKE SCALE (neu04) Nursing

SARASOTA MEMORIAL HOSPITAL. NURSING PROCEDURE NATIONAL INSTITUTE OF HEALTH STROKE SCALE (neu04) Nursing SARASOTA MEMORIAL HOSPITAL TITLE: ISSUED FOR: NURSING PROCEDURE NATIONAL INSTITUTE OF HEALTH Nursing DATE: REVIEWED: PAGES: PS1094 7/01 3/18 1 of 5 RESPONSIBILITY: RN, LPN PURPOSE: OBJECTIVE: DEFINITION:

More information

Shawke A. Soueidan, MD. Riverside Neurology & Sleep Specialists

Shawke A. Soueidan, MD. Riverside Neurology & Sleep Specialists Shawke A. Soueidan, MD Riverside Neurology & Sleep Specialists 757-221-0110 Epidemiology of stroke 2018 Affects nearly 800,000 people in the US annually Approximately 600000 first-ever strokes and 185000

More information

Valproate π Bipolar Disorders

Valproate π Bipolar Disorders «µ ÿª ß å æ ËÕ «π «Ë «â valproate π bipolar disorder πâπ ËÀ π âõ Ÿ µà ß Ê Ë π πÿπª æ Õß πµàõ â ªìπ «π «Ÿâ Ë «valproate π â πµà ßÊ â à ÕÕ ƒ Ï ª æ Õß À Õ àæ ߪ ß å º» ÕÕ ƒ ÏÀ Õ à ßµàÕ ª à«π ß ËßÕ Õ âõß ƒ

More information

Pra Urusopone M.D. Radiologist at Department of Radiology, Lerdsin General Hospital

Pra Urusopone M.D. Radiologist at Department of Radiology, Lerdsin General Hospital 16 π æπ åμâπ Delineation of Optic Nerve by Its Relationship with the Posterior Eithmoid and Sphenoid Sinuses According to Delano Classification Using Computed Tomography in Lerdsin General Hospital Pra

More information

Acute Stroke with Alteplase Administration Order Set

Acute Stroke with Alteplase Administration Order Set Review Due Date: 2017 October PATIENT CARE DERS Weight: Adverse Reactions or Intolerances Drug No Yes (list) Food No Yes (list) _ Latex No Yes Admission Admit to Neurology service: Dr. Critical Care Diagnosis:

More information

Keowali Phumkeson* Silpakorn University

Keowali Phumkeson* Silpakorn University 75 Stature Estimation and Sex Determination : An Evaluation of the Reliability of Phalange : Private Hospital Staff Case, Thailand Keowali Phumkeson* Silpakorn University àõ» Èßπ È «μ ÿª ß å æ ËÕ ÿ æ»

More information

11/27/2017. Stroke Management in the Neurocritical Care Unit. Conflict of interest. Karel Fuentes MD Medical Director of Neurocritical Care

11/27/2017. Stroke Management in the Neurocritical Care Unit. Conflict of interest. Karel Fuentes MD Medical Director of Neurocritical Care Stroke Management in the Neurocritical Care Unit Karel Fuentes MD Medical Director of Neurocritical Care Conflict of interest None Introduction Reperfusion therapy remains the mainstay in the treatment

More information

Diagnosis: Allergies with reaction type:

Diagnosis: Allergies with reaction type: Patient Name: Diagnosis: Allergies with reaction type: ICU Stroke-Ischemic S/P tpa Version 2 5/29/14 This order set is designed to be used with an admission set or for a patient already admitted Nursing

More information

NURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE PROTOCOLS. ACTIVASE (t-pa) INFUSION PROTOCOL FOR ACUTE MYOCARDIAL INFARCTION

NURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE PROTOCOLS. ACTIVASE (t-pa) INFUSION PROTOCOL FOR ACUTE MYOCARDIAL INFARCTION NURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE PROTOCOLS ACTIVASE (t-pa) FOR ACUTE MYOCARDIAL INFARCTION I. PURPOSE: A. To reduce the extent of myocardial infarction by lysing the clot in

More information

Surgical Techniques of Cataract Surgery and Subsequent Postoperative Endophthalmitis

Surgical Techniques of Cataract Surgery and Subsequent Postoperative Endophthalmitis Surgical Techniques of Cataract Surgery and Subsequent Postoperative Endophthalmitis Adisak Trinavarat MD*, La-ongsri Atchaneeyasakul MD* * Department of Ophthalmology, Faculty of Medicine Siriraj Hospital,

More information

Management of Acute Ischemic Stroke. Learning Objec=ves. What is a Stroke? Jen Simpson Neurohospitalist

Management of Acute Ischemic Stroke. Learning Objec=ves. What is a Stroke? Jen Simpson Neurohospitalist Management of Acute Ischemic Stroke Jen Simpson Neurohospitalist Learning Objec=ves Iden=fy signs/symptoms of stroke Recognize pa=ents who may be eligible for treatment of acute stroke What is a Stroke?

More information

Thrombolysis Delivery, Care, and Monitoring. 5 Acute Trusts - 6 Primary Care Trusts Ambulance Trust 4 Local Authorities

Thrombolysis Delivery, Care, and Monitoring. 5 Acute Trusts - 6 Primary Care Trusts Ambulance Trust 4 Local Authorities Thrombolysis Delivery, Care, and Monitoring Documentation & Pathways Need to follow locally agreed policies and procedures Follow thrombolysis pathway? Need to complete Sits database Weight Dose matters!

More information

Supot Pongprasobchai MD*, Thanjira Jiranantakan MD*, Akarin Nimmannit MD**, Cherdchai Nopmaneejumruslers MD*

Supot Pongprasobchai MD*, Thanjira Jiranantakan MD*, Akarin Nimmannit MD**, Cherdchai Nopmaneejumruslers MD* Comparison of the Efficacy between Lidocaine Spray plus Lidocaine Jelly Lubrication and Lidocaine Jelly Lubrication Alone Prior to Nasogastric Intubation: A Prospective Double-Blind Randomized Controlled

More information

Department Specific Guideline

Department Specific Guideline Department Specific Guideline Stroke/TIA Management ED Applicable to: Nursing/Medical staff caring Authorised by: Stroke services team for Acute stroke/tia patients Contact person: Clinical nurse manager,

More information

ND STROKE Coordinators Case Studies. STEMI and Stroke Conference, Fargo, ND, August 5, 2014

ND STROKE Coordinators Case Studies. STEMI and Stroke Conference, Fargo, ND, August 5, 2014 ND STROKE Coordinators Case Studies STEMI and Stroke Conference, Fargo, ND, August 5, 2014 STROKE Coordinator Case Study Essentia Health, Fargo Essentia Health Stroke Alert Process Within 24 hours of Last

More information

Alpha Research - TCELS - Thailand Health Data. 8.1 Top five causes of death - whole kingdom

Alpha Research - TCELS - Thailand Health Data. 8.1 Top five causes of death - whole kingdom Alpha Research - TCELS - Thailand Health Data 65 8. Cause of death no. of deaths 30,000 25,000 20,000 15,000 16,394 10,000 5,000 0 Septicaemia Cerebrovascular diseases Pneumonia Ischaemic heart diseases

More information

Stroke in the Emergency Room: What do we need to know?

Stroke in the Emergency Room: What do we need to know? Stroke in the Emergency Room: What do we need to know? Salah G. Keyrouz, MD, FAHA March 10, 2012 Stroke in the Emergency Room: What do we need to know? Disclosure: None 2 1 Outline Definition Introduction

More information

Acute Respiratory Distress Syndrome (ARDS) in Ramathibodi Hospital: Risks and Prognostic Factors

Acute Respiratory Distress Syndrome (ARDS) in Ramathibodi Hospital: Risks and Prognostic Factors «««ßÕ ««ƒμ Thai Journal of Tuberculosis Chest Diseases and Critical Care π æπ åμâπ Original Article Acute Respiratory Distress Syndrome (ARDS) in Ramathibodi Hospital: Risks and Prognostic Factors Kittima

More information

2018 Early Management of Acute Ischemic Stroke Guidelines Update

2018 Early Management of Acute Ischemic Stroke Guidelines Update 2018 Early Management of Acute Ischemic Stroke Guidelines Update Brandi Bowman, PhC, Pharm.D. April 17, 2018 Pharmacist Objectives Describe the recommendations for emergency medical services and hospital

More information

Thrombolytic therapy should be the first line treatment in acute ishchemic stroke. We are against it!!

Thrombolytic therapy should be the first line treatment in acute ishchemic stroke. We are against it!! Thrombolytic therapy should be the first line treatment in acute ishchemic stroke We are against it!! 85% of strokes are ischaemic, and related to blockage of an artery by a blood clot, so potential treatments

More information

Stroke: The First Critical Hour. Alina Candal, RN, PCC, MICN Kevin Andruss, MD, FACEP

Stroke: The First Critical Hour. Alina Candal, RN, PCC, MICN Kevin Andruss, MD, FACEP Stroke: The First Critical Hour Alina Candal, RN, PCC, MICN Kevin Andruss, MD, FACEP Disclosures We have no actual or potential conflicts of interest in relation to this presentation. Objectives Discuss

More information

Canadian Stroke Best Practices Table 3.3A Screening and Assessment Tools for Acute Stroke

Canadian Stroke Best Practices Table 3.3A Screening and Assessment Tools for Acute Stroke Canadian Stroke Best Practices Table 3.3A Screening and s for Acute Stroke Neurological Status/Stroke Severity assess mentation (level of consciousness, orientation and speech) and motor function (face,

More information

Survey of Refractive Errors among Buddhist Scripture, Dhamma-Bali and Regular School of Buddhist Novices in the Bangkok Metropolitan Area

Survey of Refractive Errors among Buddhist Scripture, Dhamma-Bali and Regular School of Buddhist Novices in the Bangkok Metropolitan Area Survey of Refractive Errors among Buddhist Scripture, Dhamma-Bali and Regular School of Buddhist Novices in the Bangkok Metropolitan Area Ubolrat Nanthavisit RN*, Jiraporn Sornchai RN*, Watanee Jenchitr

More information

Primary Stroke Center Quality & Performance Measures

Primary Stroke Center Quality & Performance Measures Primary Stroke Center Quality & Performance Measures This section of the manual contains information related to the quality performance of Primary Stroke Centers. Brain Attack Coalition Definitions Recognition

More information

The Efficacy and Safety of Intrathecal Morphine for Postoperative Pain Management in Srinagarind Hospital

The Efficacy and Safety of Intrathecal Morphine for Postoperative Pain Management in Srinagarind Hospital The Efficacy and Safety of Intrathecal Morphine for Postoperative Pain Management in Srinagarind Hospital Panaratana Ratanasuwan Yimyaem M.D.,* Duenpen Horatanaruang M.D.,* Kanchana Uppan M.D.,* Wimonrat

More information

TIA AND STROKE. Topics/Order of the day 1. Topics/Order of the day 2 01/08/2012

TIA AND STROKE. Topics/Order of the day 1. Topics/Order of the day 2 01/08/2012 Charles Ashton Medical Director TIA AND STROKE Topics/Order of the day 1 What Works? Clinical features of TIA inc the difference between Carotid and Vertebral territories When is a TIA not a TIA TIA management

More information

Table 3.1: Canadian Stroke Best Practice Recommendations Screening and Assessment Tools for Acute Stroke Severity

Table 3.1: Canadian Stroke Best Practice Recommendations Screening and Assessment Tools for Acute Stroke Severity Table 3.1: Assessment Tool Number and description of Items Neurological Status/Stroke Severity Canadian Neurological Scale (CNS)(1) Items assess mentation (level of consciousness, orientation and speech)

More information

Difference in the Yields of Bronchial Washing Cytology before and after Forceps Biopsy for Lung Cancer Diagnosis

Difference in the Yields of Bronchial Washing Cytology before and after Forceps Biopsy for Lung Cancer Diagnosis Difference in the Yields of Bronchial Washing Cytology before and after Forceps Biopsy for Lung Cancer Diagnosis Suree Sompradeekul MD*, Usana Chinvetkitvanich MD*, Panthep Suthinon MD**, Sommit Wongbunnate

More information

Shands at the University of Florida Stroke Program

Shands at the University of Florida Stroke Program Shands at the University of Florida Stroke Program The only Comprehensive Stroke Center in north central Florida as designated by the Florida Agency for Health Care Administration. To transfer a stroke

More information

DATA COLLECTION FORMS PARTICIPATING SITES

DATA COLLECTION FORMS PARTICIPATING SITES Patient Identification Number: - DATA COLLECTION FORMS PARTICIPATING SITES VISIT 1: BASELINE Inclusion criteria known at time of randomisation Yes No 1. The patient received rt-pa thrombolysis treatment

More information

ADULT POST NEUROLOGIC INTERVENTION ORDERS 2 of 4

ADULT POST NEUROLOGIC INTERVENTION ORDERS 2 of 4 9 Actual 9 Estimated DOWNTIME INTERVENTION 1 of 4 Weight kg 9 Actual 9 Estimated Height cm ALLERGIES: REFER TO ALLERGY PROFILE/ POWERCHART Admit to Dr.: Bed Type: Dx: ( ) Check, circle and/or fill in all

More information

* * FORM REV. 02/2019 Page 1 of 4. TNKASE (tenecteplase) / ACUTE STEMI ORDERS SCHEDULED MEDICATIONS:

* * FORM REV. 02/2019 Page 1 of 4. TNKASE (tenecteplase) / ACUTE STEMI ORDERS SCHEDULED MEDICATIONS: 1. Is this a CMS inpatient only procedure? Yes, admit as inpatient, proceed to # 3 No, proceed to # 2 2. Do you expect that the patient s condition will require a hospital stay that will cross two midnights

More information

Tony L Smith DNP RN ACNP CCRN CFRN EMT-IV Vanderbilt LifeFlight

Tony L Smith DNP RN ACNP CCRN CFRN EMT-IV Vanderbilt LifeFlight Treatment of a Stroke patient: A look at how to care for the Stroke patient in the aeromedical setting Tony L Smith DNP RN ACNP CCRN CFRN EMT-IV Vanderbilt LifeFlight Objectives 1. Discuss the assessment

More information

Õ µ à πµ æ.» æá Ëß πµ æ å π æ» π πµ ÿ Õπ

Õ µ à πµ æ.» æá Ëß πµ æ å π æ» π πµ ÿ Õπ Õ µ à πµ æ.». 2557 À «æ â æá Ëß πµ æ å π æ» π πµ ÿ Õπ àõ» ßæ π π È ªìπ «Àåµâπ ÿπ πµ π ÿ Õß ÕߺŸâ Àâ Õ µ à πµ «æ â πõµàõ ß π π À«à ß Õπ π - ÿπ π 2557 ««âõ Ÿ ªïß ª 2556 π«π 3 ÿà ßæ ÿ π ß滟π å/ Ë«ª â à º

More information

BY: Ramon Medina EMT-LP/RN

BY: Ramon Medina EMT-LP/RN BY: Ramon Medina EMT-LP/RN Discuss types of strokes Discuss the physical and neurological assessment of stroke patients Discuss pertinent historical findings Discuss pre-hospital and emergency management

More information

Hypertensive Haemorrhagic Stroke. Dr Philip Lam Thuon Mine

Hypertensive Haemorrhagic Stroke. Dr Philip Lam Thuon Mine Hypertensive Haemorrhagic Stroke Dr Philip Lam Thuon Mine Intracerebral Haemorrhage Primary ICH Spontaneous rupture of small vessels damaged by HBP Basal ganglia, thalamus, pons and cerebellum Amyloid

More information

11/23/2015. Disclosures. Stroke Management in the Neurocritical Care Unit. Karel Fuentes MD Medical Director of Neurocritical Care.

11/23/2015. Disclosures. Stroke Management in the Neurocritical Care Unit. Karel Fuentes MD Medical Director of Neurocritical Care. Stroke Management in the Neurocritical Care Unit Karel Fuentes MD Medical Director of Neurocritical Care Disclosures I have no relevant commercial relationships to disclose, and my presentations will not

More information

Objectives. Stroke Facts 2/27/2015. EMS in Stroke Care: A Critical Partnership

Objectives. Stroke Facts 2/27/2015. EMS in Stroke Care: A Critical Partnership EMS in Stroke Care: A Critical Partnership Spokane County EMS Objectives Identify the types and time limitations for acute ischemic stroke treatment options Identify the importance of early identification

More information

Stroke - Intracranial hemorrhage. Dr. Amitesh Aggarwal Associate Professor Department of Medicine

Stroke - Intracranial hemorrhage. Dr. Amitesh Aggarwal Associate Professor Department of Medicine Stroke - Intracranial hemorrhage Dr. Amitesh Aggarwal Associate Professor Department of Medicine Etiology and pathogenesis ICH accounts for ~10% of all strokes 30 day mortality - 35 45% Incidence rates

More information

Botulinum Toxin A in Surgically Overcorrected and Undercorrected Strabismus

Botulinum Toxin A in Surgically Overcorrected and Undercorrected Strabismus Botulinum Toxin A in Surgically Overcorrected and Undercorrected Strabismus Sorot Wutthiphan MD* *Department of Ophthalmology, Priest Hospital, Bangkok Objective: To evaluate the effectiveness and safety

More information

Case. Learning objectives. NIHSS values. Presenter Disclosure Information

Case. Learning objectives. NIHSS values. Presenter Disclosure Information 1:30 2:30 pm Primary Care of the Stroke Patient SPEAKER Thomas P. Bleck MD, MCCM, FNCS Presenter Disclosure Information The following relationships exist related to this presentation: Thomas P. Bleck,

More information

Marcey Osgood, DO Assistant Professor of Neurocritical Care UMASS Medical Center

Marcey Osgood, DO Assistant Professor of Neurocritical Care UMASS Medical Center Marcey Osgood, DO Assistant Professor of Neurocritical Care UMASS Medical Center Nothing to disclose Review common neurologic emergencies Ischemic Stroke Hemorrhagic Stroke Subarachnoid Hemorrhage Discuss

More information

Pharmacy STROKE. Anne Kinnear Lead Pharmacist NHS Lothian. Educational Solutions for Workforce Development

Pharmacy STROKE. Anne Kinnear Lead Pharmacist NHS Lothian. Educational Solutions for Workforce Development STROKE Anne Kinnear Lead Pharmacist NHS Lothian Aim To update pharmacists on Stroke: the disease and its management and explore ways to implement pharmaceutical care for this patient group as part of normal

More information

When Not To Give TPA Steve Phillips Division of Neurology

When Not To Give TPA Steve Phillips Division of Neurology When Not To Give TPA Steve Phillips Division of Neurology stephen.phillips@nshealth.ca AstraZeneca Disclosures - 1 I have given CME lectures and served on advisory boards for Boehringer Ingelheim Bristol-Myers

More information

Canadian Best Practice Recommendations for Stroke Care. (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management

Canadian Best Practice Recommendations for Stroke Care. (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management Canadian Best Practice Recommendations for Stroke Care (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management Reorganization of Recommendations 2008 2006 RECOMMENDATIONS: 2008 RECOMMENDATIONS:

More information

Stroke in the Rural Setting: How You Can Make A Difference. Susie Fisher, RN, BSN Program Manager Providence Stroke Center Portland, OR

Stroke in the Rural Setting: How You Can Make A Difference. Susie Fisher, RN, BSN Program Manager Providence Stroke Center Portland, OR Stroke in the Rural Setting: How You Can Make A Difference. Susie Fisher, RN, BSN Program Manager Providence Stroke Center Portland, OR Outline State Statistics The Oregon Problem Time & Treatments Steps

More information

Pathophysiology of stroke

Pathophysiology of stroke A practical approach to acute stro ke Dr. Sanjith Aaron, M.D., D.M., Professor, Department of Neurosciences, CMC Vellore Stroke is characterized by an abrupt onset of neurological deficit lasting more

More information

Acute Ischemic Stroke Mechanism, Diagnosis, Treatment

Acute Ischemic Stroke Mechanism, Diagnosis, Treatment Acute Ischemic Stroke Mechanism, Diagnosis, Treatment IM Resident Lecture December 2016 Mohammad Shafie, MD PhD MEng Department of Neurology UC Irvine Objectives Better understanding of stroke mechanisms

More information

HYPERACUTE STROKE CASE STUDIES. By Mady Roman Hyper Acute Stroke Nurse Practitioner RHH

HYPERACUTE STROKE CASE STUDIES. By Mady Roman Hyper Acute Stroke Nurse Practitioner RHH HYPERACUTE STROKE CASE STUDIES By Mady Roman Hyper Acute Stroke Nurse Practitioner RHH MC Case study 82 years old, lady 9:30 well, in touch with her son 11:30 hairdresser came to her house and found her

More information

DRUG ALLERGIES WT: KG

DRUG ALLERGIES WT: KG DRUG AND TREATMENT Available at: BMC-B BMC-D BMC-N BMC-S Vital Signs Vital Signs Q4H (DEF)* Q2H Q1H Vital Signs Orthostatic Activity Activity Bedrest, for 12 hours then Up ad lib (DEF)* Bedrest, for 24

More information

Acute stroke imaging

Acute stroke imaging Acute stroke imaging Aims Imaging modalities and differences Why image acute stroke Clinical correlation to imaging appearance What is stroke Classic definition: acute focal injury to the central nervous

More information

Pre-Hospital Stroke Care: Bringing It To The Street. by Bob Atkins, NREMT-Paramedic AEMD EMS Director Bedford Regional Medical Center

Pre-Hospital Stroke Care: Bringing It To The Street. by Bob Atkins, NREMT-Paramedic AEMD EMS Director Bedford Regional Medical Center Pre-Hospital Stroke Care: Bringing It To The Street by Bob Atkins, NREMT-Paramedic AEMD EMS Director Bedford Regional Medical Center Overview/Objectives Explain the reasons or rational behind the importance

More information

Stroke Guidelines. November 19, 2011

Stroke Guidelines. November 19, 2011 Stroke Guidelines November 19, 2011 Clinical Practice Guidelines American Stroke Association Guidelines are comprehensive statements that provide the highest level of scientific evidence for clinical practice.

More information

Stroke School for Internists Part 1

Stroke School for Internists Part 1 Stroke School for Internists Part 1 November 4, 2017 Dr. Albert Jin Dr. Gurpreet Jaswal Disclosures I receive a stipend for my role as Medical Director of the Stroke Network of SEO I have no commercial

More information

The Multi arm Optimization of Stroke Thrombolysis (MOST) Trial

The Multi arm Optimization of Stroke Thrombolysis (MOST) Trial The Multi arm Optimization of Stroke Thrombolysis (MOST) Trial Study Team Principal Investigators: Opeolu Adeoye, University of Cincinnati (Lead) Andrew Barreto, University of Texas Houston Jim Grotta,

More information

Stroke in the ED. Dr. William Whiteley. Scottish Senior Clinical Fellow University of Edinburgh Consultant Neurologist NHS Lothian

Stroke in the ED. Dr. William Whiteley. Scottish Senior Clinical Fellow University of Edinburgh Consultant Neurologist NHS Lothian Stroke in the ED Dr. William Whiteley Scottish Senior Clinical Fellow University of Edinburgh Consultant Neurologist NHS Lothian 2016 RCP Guideline for Stroke RCP guidelines for acute ischaemic stroke

More information

Stroke: clinical presentations, symptoms and signs

Stroke: clinical presentations, symptoms and signs Stroke: clinical presentations, symptoms and signs Professor Peter Sandercock University of Edinburgh EAN teaching course Burkina Faso 8 th November 2017 Clinical diagnosis is important to Ensure stroke

More information

CEREBRO VASCULAR ACCIDENTS

CEREBRO VASCULAR ACCIDENTS CEREBRO VASCULAR S MICHAEL OPONG-KUSI, DO MBA MORTON CLINIC, TULSA, OK, USA 8/9/2012 1 Cerebrovascular Accident Third Leading cause of deaths (USA) 750,000 strokes in USA per year. 150,000 deaths in USA

More information

Get With the Guidelines Stroke PMT. Quality Measure Descriptions

Get With the Guidelines Stroke PMT. Quality Measure Descriptions Get With the Guidelines Stroke PMT Quality Measure s Last Updated July 2016 Print Measure s Dysphagia Screen Stroke Education Rehabilitation Considered Time to Intravenous Thrombolytic Therapy 60 min LDL

More information

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG DRUG AND TREATMENT Non Categorized SUB Sub Phase (SUB)* Non Categorized Quality Measures STK Diet ED NPO Until Bedside Swallow Screen passed Nursing Orders Activate Code Stroke Vital Signs Q15MINS Int

More information

Hywel Dda Health Board Stroke Thrombolysis Care Pathway (Pembrokeshire version)

Hywel Dda Health Board Stroke Thrombolysis Care Pathway (Pembrokeshire version) Hywel Dda Health Board (Pembrokeshire version) Patient Details (attach Addressograph): Number: Name: Address: NHS Number: Date of Birth: / / Telephone Number: Religion: Postcode: Allergies: This pathway

More information

Abstract. The purposes of this descriptive research were to study brain organicity in amphetamine

Abstract. The purposes of this descriptive research were to study brain organicity in amphetamine The Study of Organic Brain in Amphetamine Dependence by Using the Wechsler Adult Intelligence Scale-Third-Edition Vichien Sriputhon* and Sucheera Phatthrayuttawat** Abstract Objective: Method: Results:

More information

Dr Ben Turner. Consultant Neurologist and Honorary Senior Lecturer Barts and The London NHS Trust London Bridge Hospital

Dr Ben Turner. Consultant Neurologist and Honorary Senior Lecturer Barts and The London NHS Trust London Bridge Hospital Stroke Management Dr Ben Turner Consultant Neurologist and Honorary Senior Lecturer Barts and The London NHS Trust London Bridge Hospital Introduction Stroke is the major cause of disability in the developed

More information

Surgical Outcomes in Rhegmatogenous Retinal Detachment at Srinagarind Hospital

Surgical Outcomes in Rhegmatogenous Retinal Detachment at Srinagarind Hospital Surgical Outcomes in Rhegmatogenous Retinal Detachment at Srinagarind Hospital Yosanan Yospaiboon MD*, Thuss Sanguansak MD*, Tanapat Ratanapakorn MD*, Suthasinee Sinawat MD* * Department of Ophthalmology

More information

Blood Pressure Management in Acute Ischemic Stroke

Blood Pressure Management in Acute Ischemic Stroke Blood Pressure Management in Acute Ischemic Stroke Kimberly Clark, PharmD, BCCCP Clinical Pharmacy Specialist Critical Care, Greenville Health System Adjunct Assistant Professor, South Carolina College

More information